The Internal Revenue Service (“IRS”) is now accepting Form 15315 certifications by mail, fax or email.
The IRS Employee Plans Group recently discovered a glitch on its Mobile Friendly Forms webpage impacting the digitalized Form 15315 multiemployer defined benefit plan administrators should use to electronically report the actuarial certification of a multiemployer defined benefit plan’s funding status. Due to the glitch, the electronic form won’t allow administrators to enter a date beyond December 31, 2025, or plan numbers beginning with 0; for example, 002.
In response to this glitch, the IRS now allows filing electronically, by mail or by fax.
Mail the form to:
Department of the Treasury
Employee Plans
CHI-7602 – 25th Floor
230 S. Dearborn Street
Chicago, IL 60604
Fax the form to:
855-215-7122
Email the form to:
EPCU@IRS.gov with Multiemployer Certification in the subject line.
For More Information Or Help
We hope this update is helpful. For more information about these or other health or other employee benefits, human resources, or health care developments, please contact the author, Cynthia Marcotte Stamer, via e-mail or telephone at (214) 452-8297.
Solutions Law Press, Inc. invites you to receive future updates by registering on our Solutions Law Press, Inc. Website and participating in and contributing to the discussions in our Solutions Law Press, Inc. LinkedIn SLP Health Care Risk Management & Operations Group, HR & Benefits Update Compliance Group, and/or Coalition for Responsible Health Care Policy.
About the Author
Cynthia Marcotte Stamer is a Martindale-Hubble AV-Preeminent (highest/top 1%) practicing attorney recognized as a “Top Woman Lawyer,” “Top Rated Lawyer,” and “LEGAL LEADER™” in Health Care Law and Labor and Employment Law; among the “Best Lawyers In Dallas” in “Labor & Employment,” “Tax: ERISA & Employee Benefits,” “Health Care” and “Business and Commercial Law recognized for her experience, scholarship, thought leadership and advocacy on HIPAA and other data and technology use, security and compliance in connection with her work with health care and life sciences, employee benefits, insurance, education, technology and other highly regulated and performance-dependent clients.
Board certified in labor and employment law by the Texas Board of Legal Specialization and a Fellow in the American College of Employee Benefits Counsel, Ms. Stamer works with these and other highly regulated or data and performance reliant businesses to design, risk manage, and defend their employment and other workforce, data and technology and other operations to promote legal and operational compliance, reduce regulatory and other liability and promote other operational goals.
Along with her decades of legal and strategic consulting experience, Ms. Stamer also contributes her leadership and experience to many professional, civic and community organizations. She currently serves as Co-Chair of the ABA Real Property Trusts and Estates (“RPTE”) Section Welfare Plan Committee, Co-Chair of the ABA International Section International Employment Law Committee and its Annual Meeting Program Planning Committee, Chair Emeritus and Vice Chair of the ABA Tort Trial and Insurance (“TIPS”) Section Medicine and Law Committee, and Chair of the ABA Intellectual Property Section Law Practice Management Committee.
Additionally, more her ABA involvements include than a decade of service as a Scribe for the Joint Committee on Employee Benefits (“JCEB”) annual agency meetings with the Department of Health and Human Services and JCEB Council Representative, International Section Life Sciences Committee Chair, RPTE Section Employee Benefits Group Chair and a Substantive Groups Committee Member, Health Law Section Managed Care & Insurance Interest Group Chair, as TIPS Section Medicine and Law Committee Chair and Employee Benefits Committee and Workers Compensation Committee Vice Chair, Tax Section Fringe Benefit Committee Chair, and in various other ABA leadership capacities. Ms. Stamer also is a former Southwest Benefits Association Board Member and Continuing Education Chair, SHRM National Consultant Board Chair and Region IV Chair, Dallas Bar Association Employee Benefits Committee Chair, former Texas Association of Business State, Regional and Dallas Chapter Chair, a founding board member and Past President of the Alliance for Healthcare Excellence, as well as in the leadership of many other professional, civic and community organizations. She also is recognized for her contributions to strengthening health care policy and charitable and community service resolving health care challenges performed under PROJECT COPE Coalition For Patient Empowerment initiative and many other pro bono service involvements locally, nationally and internationally.
Ms. Stamer is the author of many highly regarded works published by leading professional and business publishers, the ABA, the American Health Lawyers Association, and others. Ms. Stamer also frequently speaks and serves on the faculty and steering committee for many ABA and other professional and industry conferences and conducts leadership and industry training for a wide range of organizations.
For more information about Ms. Stamer or her health industry and other experience and involvements, see http://www.cynthiastamer.com or contact Ms. Stamer via telephone at (214) 452-8297 or via e-mail here.
About Solutions Law Press™
Solutions Law Press™ provides health care, insurance, human resources and employee benefit, data and technology, regulatory and operational performance, and other business risk management, legal compliance, management effectiveness and other coaching, tools and other resources, training and education. These include extensive resources on leadership, governance, human resources, employee benefits, data security and privacy, insurance, health care and other key compliance, risk management, internal controls and operational concerns. If you find this of interest, you also be interested reviewing some of our other Solutions Law Press™ resources or training.
If you or someone else you know would like to receive future updates about developments on these and other concerns, please be sure that we have your current contact information including your preferred e-mail by creating your profile here.
NOTICE: These statements and materials are for general information and purposes only. They do not establish an attorney-client relationship, are not legal advice or an offer or commitment to provide legal advice, and do not serve as a substitute for legal advice. Readers are urged to engage competent legal counsel for consultation and representation considering the specific facts and circumstances presented in their unique circumstances at the particular time. No comment or statement in this publication is to be construed as legal advice or admission. Solutions Law Press and its authors reserve the right to qualify or retract any of these statements at any time. Likewise, the content is not tailored to any particular situation and does not necessarily address all relevant issues. Because the law constantly and often evolves, subsequent developments that could impact the currency and completeness of this discussion are likely. Solutions Law Press and its authors disclaim and have no responsibility to provide any update or otherwise notify anyone of any fact or law-specific nuance, change, limitation, or other condition that might affect the suitability of reliance upon these materials or information otherwise conveyed in connection with this program. Readers may not rely upon, are solely responsible for, and assume the risk and all liabilities resulting from their use of this publication.
Circular 230 Compliance. The following disclaimer is included to ensure that we comply with U.S. Treasury Department Regulations. Any statements contained herein are not intended or written by the writer to be used, and nothing contained herein can be used by you or any other person, for the purpose of (1) avoiding penalties that may be imposed under federal tax law, or (2) promoting, marketing or recommending to another party any tax-related transaction or matter addressed herein.
Solutions Law Press Publisher and author Cynthia Marcotte Stamer will moderate a program on “Workforce Termination & Severance Around The World” at the American Bar Association (“ABA”) International Law Section 2025 Annual Conference in New York.
Countries’ laws differ for individual and mass employment terminations. During the program, labor and employment lawyers Sandra McCandless, Donald C. Dowling, and Michael Green will examine countries’ laws on termination and severance rights, responsibilities and practices, examine common issues arising when employers terminate in country and ex-patriate workers outside their home countries, and share practical insights and experiences to budget, manage and defend worker separations to minimize legal, operational and liabilities and disruptions in the United States, India, China, Latin America and other regions of the World.
Focusing on the theme Adapting to Today’s International Legal Challenges: A New Era?” the ABA expects more than 600 participants from more than 30 countries around the world to attend the Conference, which runs from from April 28 -May 1, 2025. The Conference will feature a multitude of programs focusing on a wide range of timely international law and policy issues.
Along with the “Workforce Termination & Severance Around The World program that Ms. Stamer is moderating, the International Employment Law Committee Co-Chaired by Ms. Stamer and Nadia Moynihan also is hosting two other programs during the Conference:
Global Outsourcing Strategies: Managing Legal and Operational Risks of Offshore Workers & Services;
AI at Work: Navigating Bias, Diversity, and Legal Boundaries in the Workplace.
Check out the full agenda, registration (including single day rates) and other details of the Conference here.
An management and regulatory affairs attorney Board-Certified in Labor and Employment Law by the Texas Board of Legal Specialization and American College of Employee Benefits Counsel Fellow, Ms. Stamer’s workforce and other management work, public policy leadership and advocacy, coaching, teachings, scholarship and thought leadership on helping organizations and leaders about manage their internal and external workforce, employee benefits and compensation, regulatory compliance and governmental affairs and other legal and operational practices and risk have earned her recognition as a Fellow in the American College of Employee Benefits Counsel, a “Top Woman Lawyer,” “Top Rated Lawyer,” and “LEGAL LEADER™” in Labor and Employment Law and Health Care Law; a “Best Lawyers” in “Labor & Employment,” “Tax: ERISA & Employee Benefits,” “Health Care” and “Business and Commercial Law” and numerous other honors.
For more than 35 years, Ms. Stamer’s work has advised businesses and business leaders about enhancing the effectiveness and defensibility of their operations using employment and other workforce and services management, employee benefits, compensation, performance management, contracting, Federal Sentencing Guideline and other compliance and risk management, investigations, and other legal and operational tools and solutions. While helping businesses define and manage the conduct and performance of their employees, contractors and vendors, she also assists employers and others with compliance with federal and state equal employment, compensation, health and other employee benefits, workplace safety, leave, employment tax, and other labor and employment, privacy and data security, and other laws: advises and assists management to monitor and reengineer workforce, employee benefits, compensation, safety and other policies and practices in response to regulatory, business, economic, and other developments; advises and defends businesses against labor and employment, employee benefit, wage and hour and other compensation, employment tax, fraud, Federal Sentencing Guideline and other regulatory compliance by the Department of Labor agencies, Department of Justice, Securities and Exchange Commission, Federal Trade Commission, Department of Justice, Office of Federal Contracts and Compliance, and other federal agencies; state Departments of Labor and other federal agencies; state workforce and labor, safety, workers’ compensation and other agencies; and employees, contractors, employee benefit plan participants and vendors, and others.
A former lead consultant to the Government of Bolivia on its social security privatization policy with decades of domestic and international government affairs and public policy experience, Ms. Stamer also has extensive experience providing advice to organizations, Congress and state legislators, federal and state regulators, and others about workforce, education, employee benefits, safety, health, insurance and other public policy concerns.
A prolific author and highly sought out thoughtleader, Ms. Stamer also speaks, coaches management and publishes extensively on these and other related matters.
For additional information about Ms. Stamer and her experience or to access other publications by Ms. Stamer see here or contact Ms. Stamer directly via email.
About Solutions Law Press™
Solutions Law Press™ provides health care, insurance, human resources and employee benefit, data and technology, regulatory and operational performance, and other business risk management, legal compliance, management effectiveness and other coaching, tools and other resources, training and education. These include extensive resources on leadership, governance, human resources, employee benefits, data security and privacy, insurance, health care and other key compliance, risk management, internal controls and operational concerns. If you find this of interest, you also be interested reviewing some of our other Solutions Law Press™ resources or training.
If you or someone else you know would like to receive future updates about developments on these and other concerns, please be sure that we have your current contact information including your preferred e-mail by creating your profile here.
NOTICE: These statements and materials are for general information and purposes only. They do not establish an attorney-client relationship, are not legal advice or an offer or commitment to provide legal advice, and do not serve as a substitute for legal advice. Readers are urged to engage competent legal counsel for consultation and representation considering the specific facts and circumstances presented in their unique circumstances at the particular time. No comment or statement in this publication is to be construed as legal advice or admission. Solutions Law Press and its authors reserve the right to qualify or retract any of these statements at any time. Likewise, the content is not tailored to any particular situation and does not necessarily address all relevant issues. Because the law constantly and often evolves, subsequent developments that could impact the currency and completeness of this discussion are likely. Solutions Law Press and its authors disclaim and have no responsibility to provide any update or otherwise notify anyone of any fact or law-specific nuance, change, limitation, or other condition that might affect the suitability of reliance upon these materials or information otherwise conveyed in connection with this program. Readers may not rely upon, are solely responsible for, and assume the risk and all liabilities resulting from their use of this publication.
Circular 230 Compliance. The following disclaimer is included to ensure that we comply with U.S. Treasury Department Regulations. Any statements contained herein are not intended or written by the writer to be used, and nothing contained herein can be used by you or any other person, for the purpose of (1) avoiding penalties that may be imposed under federal tax law, or (2) promoting, marketing or recommending to another party any tax-related transaction or matter addressed herein.
Conduct an appropriate risk analysis and take the required steps to protect your electronic health records from phishing and other hacking threats by conducting a thorough risk analysis and otherwise cleaning up your Health Insurance Portability and Accountability Act of 1996 compliance! That’s the clear message to the Department of Health and Human Services Office of Civil Rights (“OCR”) warns health plans and insurers, health care providers, health care clearinghouses (“Covered Entities”) and their business associates (collectively “Regulated Entities”) to learn from the $600,000 HIPAA Privacy, Security, and Breach Notification Rules (“HIPAA Rules”) settlement with Southern California health care network PIH Health, Inc. (“PIH”) the Department of Health & Human Services Office of Civil Rights (“OCR”) announced on April 23, 2025 and the deluge of other ongoing hacking-related HIPAA investigations OCR still is working to resolve.
Phishing & Other Hacking Events Common Cause of Health Plan Breaches
Hacking incidents present a significant cybersecurity threat to health plans and other Regulated Entities’ electronic health and other data. Phishing and other hacking attacks are among the most common types of large breaches reported to OCR every year. Over the past five years, there has been a 256% increase in large breaches reported to OCR involving hacking and a 264% increase in ransomware. In 2023, hacking accounted for 79% of the large breaches reported to OCR.
Look for more of these enforcement actions to emerge soon. Between January 1 and April 23, 2025 alone, OCR received 161 hacking-related breach reports from Regulated Entities. OCR’s Breach Portal indicates that on April 23, 2025, OCR had a total of 554 open hacking-related breach investigations, 506 involving health care providers, 47 involving health plans, and one involving a health care clearinghouse.
Health plans and other Regulated Entities will want to take appropriate actions to avoid becoming subject to breaches subjecting them to these investigations and enforcement actions, particularly with OCR Acting Director Anthony Archeval warninghealth plans and other Regulated Entities:
Ransomware and hacking are the primary cyber-threats to electronic protected health information within the health care industry. Failure to conduct a HIPAA risk analysis puts this information at risk and vulnerable to future ransomware attacks and other cyber-threats[.]
Duty To Analyze & Manage Hacking & Other Susceptibilities
The HIPAA Privacy, Security, and Breach Notification Rules require Regulated Entities to take specific actions as warranted by their threat susceptibility to protect the privacy and security of electronic protected health information (“ePHI”) from hacking and other improper access, destruction, or disclosure. At the heart of these requirements is the requirement that health plans and other Regulated Entities conduct documented risk analyses of their assessment of the susceptibility information of their ePHI to hacking and other threats. As reflected in the following table of current HIPAA sanctions, violation of these HIPAA requirements exposes a Regulated Entity to significant civil monetary penalties or criminal sanctions.
The HIPAA Security Rule requires a Regulated Entity to conduct an “accurate and thorough assessment of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of ePHI” and “[i]mplement policies and procedures to prevent, detect, contain, and correct security violations.” Meanwhile, the HIPAA Breach Notification Rule requires in 45 CFR § 164.402 that a Regulated Entity that experiences an impermissible acquisition, access, use, or disclosure (“breach”) of unsecured ePHI to conduct a documented risk assessment to determine whether the Regulated Entity must notify affected individuals, OCR and in the case of breaches involving the ePHI of 500 or more individuals, the media. OCR interprets these Rules together also to require Regulated Entities experiencing a breach of ePHI or having evidence putting the Regulated Entity on notice of a potential susceptibility creating a risk of a breach as triggering a duty by the Regulated Entity to conduct a Risk Assessment to assess the susceptibility of its ePHI to the risk and the actions reasonably necessary to mitigate it under the Security Rule.
OCR views Risk Analysis as foundational to the protection of ePHI. Consequently, OCR constantly has urged Regulated Entities to fulfill their Risk Analysis obligations since the earliest days of HIPAA in its guidance and educational outreach, as well as by regularly discussing the requirement and role of Risk Analysis deficiencies in creating the circumstances leading to enforcement actions against Regulated Entitles in its civil monetary penalty assessments and HIPAA settlement announcements.
Despite OCR’s constant and ever-rising efforts to promote compliance with the Risk Analysis requirements, however, OCR consistently has found deficiencies in Regulated Entities’ Risk Analysis in its breach investigations and audit findings since these rules became effective. As the number and magnitude of reported breaches of ePHI skyrocketing and massive breaches like those experienced in 2024 by UnitedHealthcare subsidiary Change Health, Ascension and others demonstrating the serious consequences ransomware and other cyberattacks can inflict on health care delivery, payment, and patient privacy, OCR is placing new emphasis on tightening both the requirements for Risk Analysis and its enforcement of compliance with the Risk Analysis requirements.
Look for OCR both to continue zealously to enforce the Risk Analysis and other HIPAA Security Rule compliance and to tighten thesed requirements. On December 27, 2024, for instance, OCR published a notice of proposed rulemaking that proposes to clarify and tighten significantly the Risk Analysis requirements and other elements of the HIPAA Security Rule. Along with proposing these heightened Risk Analysis requirements, OCR announced and now is zealously enforcing the current Risk Analysis requirements through its Risk Analysis Initiative to hold Regulated Entities accountable for failing to fulfill their Risk Analysis responsibilities as part of its heightened efforts to improve Regulated Entities’ fulfillment of their Risk Analysis obligations. Prior to its announcement of the PIH settlement, OCR in recent months announced seven Risk Analysis Initiative settlements, including three in April.
Breaches & Other Security Rule Violations Carry Substantial Liability Risks
Reasonable Cause or No Knowledge of Violation: Up to 1 year imprisonment
2
Reasonable Cause: $1,424 – $71,162 per violation
PHI Obtained Under False Pretenses: Up to 5 years imprisonment
3
Willful Neglect (corrected within 30 days): $14,232 – $71,162 per violation
PHI Obtained for Personal Gain or with Malicious Intent: Up to 10 years imprisonment
4
Willful Neglect (not corrected within 30 days): $71,162 – $2,134,831 per violation
Most Regulated Entities that OCR accused of violating the HIPAA requirements avoid paying the full amount of authorized civil monetary penalties by accepting OCR settlement offers. As the $600,000 PIH and other settlements demonstrate, however, settlement with OCR allows Regulated Entities to avoid much greater potential civil monetary penalties by paying a much smaller, but still generally significant, settlement amount. As significant as these penalties and settlement costs are, they typically reflect only a small portion of the true cost organizations suffer from a breach. With the average financial consequences suffered by organizations that experience a data breach now approaching $5 million, costs of investigation and recovery from a breach and the associated operational and business disruptions experienced inflict a heavy toll even where OCR allows the health plan or other Regulated Entity to resolve its exposures with no financial settlement or penalty.
Breaches & Other Security Rule Violations Create Substantial Liability For Plans & Their Fiduciaries
Although OCR’s PIH settlement announcement does not label the settlement as a Risk Analysis Initiative, OCR’s discussion makes clear OCR considered PIH’s failure to fulfill the Risk Analysis requirements a core failure contributing to the breach. The PIH settlement resolves an investigation that OCR conducted after receiving a breach report from PIH in January 2020 about a June 2019 phishing attack. The report stated the attack compromised forty-five of its employees’ email accounts, resulting in the breach of 189,763 individuals’ unsecured ePHI. PIH reported that the ePHI disclosed in the phishing attack included affected individuals’ names, addresses, dates of birth, driver’s license numbers, Social Security numbers, diagnoses, lab results, medications, treatment and claims information, and financial information.
OCR’s investigation found multiple potential violations of the HIPAA Rules, including:
Failure to use or disclose protected health information only as permitted or required by the HIPAA Privacy Rule.
Failure to conduct an accurate and thorough risk analysis of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of ePHI held by PIH.
Failure to notify affected individuals, the HHS Secretary, and the media of a breach of unsecured protected health information within 60 days of its discovery.
Under the terms of the resolution agreement, PIH has agreed to implement a corrective action plan that OCR will monitor for two years and pay a $600,000 settlement to OCR. Under the corrective action plan, PIH is obligated to take definitive steps toward resolving potential violations of the HIPAA Rules, including:
Conducting an accurate and thorough risk analysis of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of its ePHI.
Developing and implementing a risk management plan to address and mitigate security risks and vulnerabilities identified in its risk analysis.
Developing, maintaining, and revising, as necessary, its written policies and procedures to comply with the HIPAA Rules.
Training its workforce members who have access to PHI on its HIPAA policies and procedures.
The findings of deficiencies in PIH’s risk analysis and requirements that PIH conduct an accurate and thorough risk analysis and implement a risk management plan to address and mitigate identified security risks and vulnerabilities are a recurrent theme in OCR breach investigations. OCR’s recent addition of a Risk Analysis Initiative to its compliance and enforcement priorities heightens the significance of OCR’s inclusion of these findings and requirements in the PIH settlement.
Previous Health Plan Enforcement Actions Confirms Health Plan Face Similar HIPAA Exposures
In January 2021, for instance, OCR announced New York health insurer, Excellus Health Plan, Inc., would pay $5.1 million to settle potential HIPAA violations related to a breach affecting over 9.3 million people. The settlement resulted from OCR’s investigation of a September 9, 2015, breach report that cyber-attackers gained unauthorized access to its information technology systems. Excellus Health Plan reported that the breach began on or before December 23, 2013, and ended on May 11, 2015. The hackers installed malware and conducted reconnaissance activities that ultimately resulted in the impermissible disclosure of the protected health information of more than 9.3 million individuals, including their names, addresses, dates of birth, email addresses, Social Security numbers, bank account information, health plan claims, and clinical treatment information. The resolution payment is the second largest collected by OCR to date.
In October, 2020, OCR announced a resolution agreement with Aetna Life Insurance Company and affiliated covered entity (Aetna) where Aetna paid a $1 million resolution payment to settle potential HIPAA violations that arose from Aetna’s filing of hacking related breach reports in 2017 and OCR’s September 2021 announcement of a resolution agreement where Premera Blue Cross (PBC) agreed to pay $6.85 million to OCR (the second largest in OCR history) to settle potential HIPAA violations related to a breach affecting over 10.4 million people. This resolution represents the third largest payment to resolve a HIPAA investigation in OCR history.
In each of these and all subsequent breach enforcement announcements and other guidance, OCR also persistently urges health plans and other regulated entities to perform the required documented risk assessments and take the required actions necessary to guard their ePHI from hackers and other susceptibilities.
Required & Recommended Actions To Promote Defensibility Of Risk Analysis Compliance
With cyberattacks targeting health care and other Regulated Entities soaring and OCR stepping up its scrutiny of Regulated Entities’ Risk Analysis compliance in audits and enforcement actions, each health care provider and other Regulated Entity should review and tighten its Risk Analysis practices and documentation to reduce its susceptibility to potential breaches and to promote its ability to defend its compliance with the Risk Analysis requirements in the event of a breach investigation or audit.
Fulfill Current Risk Analysis Standards
To fulfill the “Risk Analysis” implantation specification, the Security Management Process Standard requires Regulated Entities enforce appropriate administrative, physical, and technical safeguards for the confidentiality, integrity, and security of electronic protected health information (“ePHI”) based on an up-to-date conduct of an up-to-date accurate and thorough assessment of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of ePHI held by that organization (“Risk Analysis”).
The Security Rule requires Regulated Entities to document each Risk Analysis in writing, to keep Risk Analysis documentation for six years, and to provide Risk Analysis documentation to OCR upon request.
Among other things, the Risk Analysis implementation standard requires regulated entities adequately to:
Identify where ePHI is located in the organization, including how ePHI enters, flows through, and leaves the organization’s information systems.
Integrate Risk Analysis and risk management into the organization’s business processes.
Ensure that audit controls are in place to record and examine information system activity.
Implement regular reviews of information system activity.
Utilize mechanisms to authenticate information to ensure only authorized users are accessing ePHI.
Encrypt ePHI in transit and at rest to guard against unauthorized access to ePHI when appropriate.
Incorporate lessons learned from incidents into the organization’s overall security management process.
Provide workforce members with regular HIPAA training that is specific to the organization and to the workforce members’ respective job duties.
Follow Proposed Rules & Enforcement Actions To Mitigate Risks
The proposed rule published by OCR on December 27, 2024, seeks to clarify and expand the original requirements of the Risk Assessment implementation standard based on OCR’s past HIPAA Security and Breach Rule investigation and enforcement experience. Under the proposed rule, a Regulated Entity’s Risk Analysis also would be required to include:
Require the development and revision of a technology asset inventory and a network map that illustrates the movement of ePHI throughout the regulated entity’s electronic information system(s) on an ongoing basis, at least once every 12 months and in response to a change in the regulated entity’s environment or operations that may affect ePHI.
Require greater specificity for conducting a risk analysis, including a written assessment that contains, among other things:
A review of the technology asset inventory and network map;
Identification of all reasonably anticipated threats to the confidentiality, integrity, and availability of ePHI;
Identification of potential vulnerabilities and predisposing conditions to the regulated entity’s relevant electronic information systems;
An assessment of the risk level for each identified threat and vulnerability, based on the likelihood that each identified threat will exploit the identified vulnerabilities; and
A review of the technology asset inventory and network map.
Other changes included in the proposed rule would further heighten the Risk Analysis and other Security Standard requirements for Regulated Entities. For instance, the proposed rule would require Regulated Entities:
To establish written procedures to restore the loss of certain relevant electronic information systems and data within 72 hours;
To perform an analysis of the relative criticality of their relevant electronic information systems and technology assets to determine the priority for restoration;
To establish written security incident response plans and procedures documenting how workforce members are to report suspected or known security incidents and how the regulated entity will respond to suspected or known security incidents;
To implement written procedures for testing and revising written security incident response plans;
To conduct a compliance audit at least once every 12 months to ensure their compliance with the Security Rule requirements;
To require business associates to verify at least once every 12 months for covered entities (and that business associate contractors verify at least once every 12 months for business associates) that they have deployed technical safeguards required by the Security Rule to protect ePHI through a written analysis of the business associate’s relevant electronic information systems by a subject matter expert and a written certification that the analysis has been performed and is accurate;
To encrypt ePHI at rest and in transit, with limited exceptions;
To establish and deploy technical controls for configuring relevant electronic information systems, including workstations, in a consistent manner including deployment of anti-malware protection, removal of extraneous software, and disabling network ports in accordance with the regulated entity’s risk analysis;
Use of multi-factor authentication, with limited exceptions;
Vulnerability scanning at least every six months and penetration testing at least once every 12 months;
Network segmentation;
Separate technical controls for backup and recovery of ePHI and relevant electronic information systems;
To review and test the effectiveness of certain security measures at least once every 12 months, in place of the current general requirement to maintain security measures;
Business associates to notify covered entities (and subcontractors to notify business associates) upon activation of their contingency plans without unreasonable delay, but no later than 24 hours after activation;
Group health plans to include in their plan documents requirements for their group health plan sponsors to: comply with the administrative, physical, and technical safeguards of the Security Rule; ensure that any agent to whom they provide ePHI agrees to implement the administrative, physical, and technical safeguards of the Security Rule; and notify their group health plans upon activation of their contingency plans without unreasonable delay, but no later than 24 hours after activation.
To help Regulated Entities understand and fulfill these responsibilities, OCR alone and in conjunction with the Office of the National Coordinator for Health Information Technology (“ONC”) also has published guidance like the HIPAA Security Risk Assessment (SRA) Tool. OCR guidance reflects that fulfillment of the Tool can help Regulated Entities may help defend but does not guarantee fulfillment of the Risk Assessment requirements, as the adequacy of the Risk Assessment always depends upon the unique facts and circumstances of the Regulated Entity at a particular time. This guidance confirms the importance of conducting timely and appropriate Risk Analysis in a manner that shows the Regulated Entity appropriately evaluated the risks to its e-PHI and acted reasonably in designing, administering, and updating that Risk Analysis to reasonably defend its e-PHI against breaches or other susceptibilities.
Since OCR’s guidance makes clear that the adequacy of a Regulated Entity’s Risk Analysis and other HIPAA Security compliance based on its evaluation and response to known and suspected susceptibility threats as conducted and documented pursuant to the Risk Analysis rule, health care providers and other Regulated Entities should view Risk Analysis as an ongoing process. While the Security Rule does not currently dictate how frequently a regulated entity must perform Risk Analysis, a proposed rule published by OCR on December 27, 2024 seeks to amend the existing Security Rule to expand the requirement to require regulated entities to develop and revise a technology asset inventory and a network map that illustrates the movement of ePHI throughout the regulated entity’s electronic information system(s) on an ongoing basis, at least once every 12 months and in response to a change in the regulated entity’s environment or operations that may affect ePHI. Although OCR has not officially adopted this and other changes contained in the proposed rule, substantial evidence exists that it already regularly administers the Risk Analysis requirement with the expectation that regulated entities will perform Risk Analysis at least this frequently. For instance, current OCR resolution agreements require impacted organizations to conduct Risk Analysis to identify and address vulnerabilities at least annually, and more frequently as needed in response to signs of potential breach or susceptibility. Likewise, since OCR developed the proposed rule from its past enforcement experience, wise Regulated Entities also will recognize the value of drawing upon the changes set forth in the proposed rule for helpful insights to strengthen the security of their ePHI generally and promoting the defensibility of the adequacy of their Risk Assessments.
Additional Responsibilities & Risks For Health Plan Fiduciaries & Sponsors
Along side the OCR warnings, employment and union sponsored health plans, their sponsors, insurers, business associates and fiduciaries also now face additional pressure to take appropriate steps to security health plan data and timely investigate and report breaches.
prudent steps to secure their health plans’ protected health information and electronic data systems against improper use, access, destruction or disclosure under April, 2021 Employee Benefit Security Administration (“EBSA”) guidance package that for the first time officially recognizes cybersecurity as included in the fiduciary responsibilities of employee benefit plan fiduciaries under the Employee Retirement Income Security Act (“ERISA”) and addition of cybersecurity to its plan audits. As a result, in addition to complying with HIPAA, ERISA-covered health plan fiduciaries and sponsors also should be prepared to demonstrate that plan fiduciaries have taken the steps prudently necessary to guard health and other employee benefit plan data and systems against cybersecurity threats. In light of this guidance health plan fiduciaries and sponsors generally will want to ensure that at minimum, they can demonstrate that the health plan and health plan vendor cybersecurity safeguard meet or exceed the recommendations included in the following guidance materials published by EBSA as part of this cybersecurity announcement and any other steps that are prudent to guard against cybersecurity threats:
Tips for Hiring a Service Provider: Helps plan sponsors and fiduciaries prudently select a service provider with strong cybersecurity practices and monitor their activities, as ERISA requires.
Online Security Tips: Offers plan participants and beneficiaries who check their retirement accounts online basic rules to reduce the risk of fraud and loss.
In light of this OCR and EBSA guidance, health plan sponsors, fiduciaries and vendors and other HIPAA covered entities and business associates are urged to take documented steps to audit and strengthen as needed their safeguards against hacking and other cybersecurity threats including:
In the case of any health plan or health plan vendor, taking well documented steps to assess and tighten as necessary their health plan systems and data security to meet or exceed the recommendation outlined in the EBSA cybersecurity guidance or otherwise necessary to prudently guard their plans and plan data and systems against cybersecurity threats.
Reviewing and monitoring on a documented, ongoing basis the adequacy and susceptibilities of existing practices, policies, safeguards of their own organizations, as well as their business associates and their vendors within the scope of attorney-client privilege taking into consideration data available from OCR, data regarding known or potential susceptibilities within their own operations as well as in the media, and other developments to determine if additional steps are necessary or advisable.
Updating policies, privacy and other notices, practices, procedures, training and other practices as needed to promote compliance and defensibility.
Renegotiating and enhancing service provider agreements to detail the specific compliance, audit, oversight and reporting rights, workforce and vendor credentialing and access control, indemnification, insurance, cooperation and other rights and responsibilities of all entities and individuals that use, access or disclose, or provide systems, software or other services or tools that could impact on security; to clarify the respective rights, procedures and responsibilities of each party in regards to compliance audits, investigation, breach reporting, and mitigation; and other relevant matters.
Verifying and tightening technological and other tracking, documentation and safeguards and controls to the use, access and disclosure of protected health information and systems.
Conducting well-documented training as necessary to ensure that members of the workforce of each covered entity and business associate understand and are prepared to comply with the expanded requirements of HIPAA, understand their responsibilities and appropriate procedures for reporting and investigating potential breaches or other compliance concerns, and understand as well as are prepared to follow appropriate procedures for reporting and responding to suspected violations or other indicia of potential security concerns.
Tracking and reviewing on a systemized, well-documented basis actual and near miss security threats to evaluate, document decision-making and make timely adjustments to policies, practices, training, safeguards and other compliance components as necessary to identify and resolve risks.
Establishing and providing well-documented monitoring of compliance that includes board level oversight and reporting at least quarterly and sooner in response to potential threat indicators.
Establishing and providing well-documented timely investigation and redress of reported violations or other compliance concerns.
Establishing contingency plans for responding in the event of a breach.
Establishing a well-documented process for monitoring and updating policies, practices and other efforts in response to changes in risks, practices and requirements.
Preparing and maintaining a well-documented record of compliance, risk, investigation and other security activities.
Pursuing other appropriate strategies to enhance the covered entity’s ability to demonstrate its compliance commitment both on paper and in operation.
Because susceptibilities in systems, software and other vendors of business associates, covered entities and their business associates should use care to assess and manage business associate and other vendor associated risks and compliance as well as tighten business associate and other service agreements to promote the improved cooperation, coordination, management and oversight required to comply with the new breach notification and other HIPAA requirements by specifically mapping out these details.
Leaders of covered entities or their business associates also are cautioned that while HIPAA itself does not generally create any private right of action for victims of breach under HIPAA, breaches may create substantial liability for their organizations or increasingly, organizational leaders under state data privacy and breach, negligence or other statutory or common laws. In addition, physicians and other licensed parties may face professional discipline or other professional liability for breaches violating statutory or ethical standards. Meanwhile, the Securities and Exchange Commission has indicated that it plans to pursue enforcement against leaders of public health care or other companies that fail to use appropriate care to ensure their organizations comply with privacy and data security obligations and the Employee Benefit Security Administration recently has issued guidance recognizing prudent data security practicces as part of the fiduciary obligations of health plans and their fiduciaries.
Appropriate Processes Can Prevent Breaches & Enhance Defensibility
With the continued explosion in ransomware and other cyberthreats heightening the risk of experiencing a breach or other incident likely to draw the attention of OCR, each health plan or other Regulated Entity should take assess and confirm the adequacy of their current Risk Analysis, both to protect its ePHI and to promote its ability to defend its compliance with the HIPAA Security Rule’s Risk Analysis and other requirements in light of OCR’s heightened emphasis on Risk Analysis compliance and enforcement. For purposes of conducting this analysis, Regulated Entities generally will want to use a process like the following to structure their evaluation of their existing Risk Analysis to take advantage of the opportunity to use attorney-client privilege and other evidentiary rules to help protect discoverability of sensitive discussions about possible deficiencies in their existing Risk Analysis and discussions about potential tradeoffs considered in current or future Risk Analysis response:
Engage legal counsel experienced with HIPAA and other cybersecurity-related risks and liabilities to advise and assist your organization in designing and administering your Risk Analysis processes and response within the scope of attorney-client privilege;
Appoint and designate leadership and technical leadership for team responsible for design and administration of your organization’s initial and ongoing cybersecurity Risk Analysis and response (“Cyber-Risk Team”) and process for board and senior management reporting of the Cyber-Risk Team;
Select and engage outside consulting service providers, cyber-liability insurers and other risk service providers expected to participate in the process; work with qualified legal counsel to contract with these business associates to include the business associate agreement and other reassurances required by the HIPAA Privacy, Security and Breach Notification Rule and other performances, cooperation to provide and back services in accordance with agreed-upon protocols in the contract;
Train Cyber-Risk Team in the appropriate processes for working with internal teams, outside service providers, leadership, and designated legal counsel to conduct Risk Analysis, investigation and response using attorney-client privilege and other evidentiary tools and processes to maximize defensibility;
Require the Cyber-Risk Team conduct an updated, document assessment of cyber-risk within scope of attorney-client privilege and work with legal counsel to develop a documented cyber-risk policy that captures analysis and determinations for your justification for the size, scope and timing of your periodic Risk Analysis and rules and processes for interim risk identification, reassessments and response in reaction to potential cyber-risk signs between periodic Risk Analysis for presentation and approval by the Board taking into account the insights from published final and proposed guidance, enforcement actions and industry standards;
Require, oversee and enforce Cyber-Risk Team’s documented administration of the initial and subsequently required Risk Analysis and response pursuant to the adopted cyber-risk policy to identify vulnerabilities and work with legal counsel within the scope of privilege to document your analysis and justifications for addressing identified vulnerabilities and other required actions in response to identified susceptibilities or event;
Review adequacy of incident detection and response arrangements, including reporting and response mechanisms, insurance and indemnification protection, and other critical elements for mitigation and recovery; and
Other actions as warranted based on advice of counsel taking into account emerging threats, guidance, and risk susceptibility.
Although civil monetary penalties or settlements are the most common sanction imposed for HIPAA Security and Breach Notification rule violations, willful and certain other violations of HIPAA can trigger criminal liability subject to the Federal Sentencing Guidelines. Consequently, beyond fulfilling the specific requirements of HIPAA, an adequate Risk Assessment also can be an invaluable tool for helping mitigate Federal Sentencing Guideline exposures of a Regulated Entity and its leaders under the Federal Sentencing Guidelines Organizational Liability rules.
Beyond these specific HIPAA-associated exposures, Regulated Entities and their leaders should keep in mind that HIPAA is likely only one of many laws that define their responsibilities to secure, report, and respond to breaches of ePHI or other sensitive data. Depending on the location, nature and other circumstances, Regulated Entities and their leaders also may have additional responsibilities and liability exposures under a variety of other federal and state laws, ethical or other professional standards, and contractual obligations in addition to those imposed under HIPAA and ERISA. For instance, inadequate data safeguards for ePHI also can trigger liability under the Fair and Accurate Credit Transactions Act, the Federal Trade Commission Act, and various electronic crimes statutes. The Securities and Exchange Commission rules can trigger disclosure and other obligations for publicly traded hospital or other health care providers, insurers, or their business associates. Health care providers, payers and others are likely to face specific additional health care or insurance-specific licensing and ethics rules, as well as other confidential information privacy, cybersecurity and breach reporting obligations and liability under various state statutes and regulations. Regulated Entities and their leaders generally will want to fully evaluate and manage these risks in conjunction with their compliance with the Risk Analysis and other requirements of the HIPAA Security and Breach Notification Rules.
Finally, health plans and other Regulated Entities are reminded that appropriate strategic planning, ongoing diligence in monitoring and responding to security events and susceptibility, and timely and appropriate use of appropriate evidentiary and procedural tools can critically impact the defensibility of pre-breach, breach investigation and post-breach investigation and decision-making. Because HIPAA, EBSA and other rules typically require prompt investigation and response to known or suspected hacking or other cybersecurity threats, health plans and other covered entities or business associates should seek the assistance of experienced legal counsel to advise and assist in these activities to understand the potential availability and proper use of these and other evidentiary rules as part of the compliance planning process as well as to prepare for appropriate use in the event of a known or suspected incident to avoid unintentional compromise of these protections.
The author of this update, Cynthia Marcotte Stamer is nationally known and celebrated for her experience providing advice and representation to health care providers, health insurers, employers and other health plan sponsors, health plans, health plan fiduciaries and administrators, third party administrators, human resources and health plan technology, and other businesses about HIPAA and other compliance, risk management and operational matters. If you have questions or need advice or help evaluating or addressing these or other compliance, risk management, or other concerns, contact her.
For More Information Or Help
We hope this update is helpful. For more information about these or other health or other employee benefits, human resources, or health care developments, please contact the author, Cynthia Marcotte Stamer, via e-mail or telephone at (214) 452-8297.
Solutions Law Press, Inc. invites you to receive future updates by registering on our Solutions Law Press, Inc. Website and participating in and contributing to the discussions in our Solutions Law Press, Inc. LinkedIn SLP Health Care Risk Management & Operations Group, HR & Benefits Update Compliance Group, and/or Coalition for Responsible Health Care Policy.
About the Author
Cynthia Marcotte Stamer is a Martindale-Hubble AV-Preeminent (highest/top 1%) practicing attorney recognized as a “Top Woman Lawyer,” “Top Rated Lawyer,” and “LEGAL LEADER™” in Health Care Law and Labor and Employment Law; among the “Best Lawyers In Dallas” in “Labor & Employment,” “Tax: ERISA & Employee Benefits,” “Health Care” and “Business and Commercial Law recognized for her experience, scholarship, thought leadership and advocacy on HIPAA and other data and technology use, security and compliance in connection with her work with health care and life sciences, employee benefits, insurance, education, technology and other highly regulated and performance-dependent clients.
Board certified in labor and employment law by the Texas Board of Legal Specialization and a Fellow in the American College of Employee Benefits Counsel, Ms. Stamer works with these and other highly regulated or data and performance reliant businesses to design, risk manage, and defend their employment and other workforce, data and technology and other operations to promote legal and operational compliance, reduce regulatory and other liability and promote other operational goals.
Along with her decades of legal and strategic consulting experience, Ms. Stamer also contributes her leadership and experience to many professional, civic and community organizations. She currently serves as Co-Chair of the ABA Real Property Trusts and Estates (“RPTE”) Section Welfare Plan Committee, Co-Chair of the ABA International Section International Employment Law Committee and its Annual Meeting Program Planning Committee, Chair Emeritus and Vice Chair of the ABA Tort Trial and Insurance (“TIPS”) Section Medicine and Law Committee, and Chair of the ABA Intellectual Property Section Law Practice Management Committee.
Additionally, more her ABA involvements include than a decade of service as a Scribe for the Joint Committee on Employee Benefits (“JCEB”) annual agency meetings with the Department of Health and Human Services and JCEB Council Representative, International Section Life Sciences Committee Chair, RPTE Section Employee Benefits Group Chair and a Substantive Groups Committee Member, Health Law Section Managed Care & Insurance Interest Group Chair, as TIPS Section Medicine and Law Committee Chair and Employee Benefits Committee and Workers Compensation Committee Vice Chair, Tax Section Fringe Benefit Committee Chair, and in various other ABA leadership capacities. Ms. Stamer also is a former Southwest Benefits Association Board Member and Continuing Education Chair, SHRM National Consultant Board Chair and Region IV Chair, Dallas Bar Association Employee Benefits Committee Chair, former Texas Association of Business State, Regional and Dallas Chapter Chair, a founding board member and Past President of the Alliance for Healthcare Excellence, as well as in the leadership of many other professional, civic and community organizations. She also is recognized for her contributions to strengthening health care policy and charitable and community service resolving health care challenges performed under PROJECT COPE Coalition For Patient Empowerment initiative and many other pro bono service involvements locally, nationally and internationally.
Ms. Stamer is the author of many highly regarded works published by leading professional and business publishers, the ABA, the American Health Lawyers Association, and others. Ms. Stamer also frequently speaks and serves on the faculty and steering committee for many ABA and other professional and industry conferences and conducts leadership and industry training for a wide range of organizations.
For more information about Ms. Stamer or her health industry and other experience and involvements, see http://www.cynthiastamer.com or contact Ms. Stamer via telephone at (214) 452-8297 or via e-mail here.
About Solutions Law Press™
Solutions Law Press™ provides health care, insurance, human resources and employee benefit, data and technology, regulatory and operational performance, and other business risk management, legal compliance, management effectiveness and other coaching, tools and other resources, training and education. These include extensive resources on leadership, governance, human resources, employee benefits, data security and privacy, insurance, health care and other key compliance, risk management, internal controls and operational concerns. If you find this of interest, you also be interested reviewing some of our other Solutions Law Press™ resources or training.
If you or someone else you know would like to receive future updates about developments on these and other concerns, please be sure that we have your current contact information including your preferred e-mail by creating your profile here.
NOTICE: These statements and materials are for general information and purposes only. They do not establish an attorney-client relationship, are not legal advice or an offer or commitment to provide legal advice, and do not serve as a substitute for legal advice. Readers are urged to engage competent legal counsel for consultation and representation considering the specific facts and circumstances presented in their unique circumstances at the particular time. No comment or statement in this publication is to be construed as legal advice or admission. Solutions Law Press and its authors reserve the right to qualify or retract any of these statements at any time. Likewise, the content is not tailored to any particular situation and does not necessarily address all relevant issues. Because the law constantly and often evolves, subsequent developments that could impact the currency and completeness of this discussion are likely. Solutions Law Press and its authors disclaim and have no responsibility to provide any update or otherwise notify anyone of any fact or law-specific nuance, change, limitation, or other condition that might affect the suitability of reliance upon these materials or information otherwise conveyed in connection with this program. Readers may not rely upon, are solely responsible for, and assume the risk and all liabilities resulting from their use of this publication.
Circular 230 Compliance. The following disclaimer is included to ensure that we comply with U.S. Treasury Department Regulations. Any statements contained herein are not intended or written by the writer to be used, and nothing contained herein can be used by you or any other person, for the purpose of (1) avoiding penalties that may be imposed under federal tax law, or (2) promoting, marketing or recommending to another party any tax-related transaction or matter addressed herein.
With the financial impact to businesses suffering data breaches in 2024 now averaging nearly $5 million and the announcement by the Department of Health and Human Services Office of Civil Rights (“OCR”) two additional Health Insurance Portability & Accountability Act (“HIPAA”) “Risk Analysis Initiative” settlements in seven days, health plans, health care providers, healthcare clearinghouses (“Covered Entities”) and their business associates (collectively “Regulated Entities”) face a growing imperative to act now to promote the defensibility of their practices under the Risk Analysis and other HIPAA Privacy, Security, and Breach Notification Rule requirements. Coupled with OCR’s steady announcement of enforcement actions like those announced this month against NERAD and others under its Risk Analysis Initiative, OCR clearly health plans and other Regulated Entities to clean up and strengthen their Risk Analysis and other HIPAA Security Rule compliance.
The need for Regulated Entities to ensure their fulfillment of HIPAA’s Risk Analysis requirements to prevent and mitigate their legal, financial and operational exposures from breaches of electronic protected health information (“ePHI”) and to defend against a potential OCR Risk Analysis enforcement action or audit is demonstrated by OCR’s announcement of HIPAA Security Rule enforcement actions and settlements with Northeast Radiology, P.C. (NERAD) on April 10, 2025, and Guam Memorial Hospital Authority (“GMHA”) on April 17, 2025, the sixth and seventh under OCR’s recently announced HIPAA “Risk Analysis Initiative” .
Risk Analysis Longstanding HIPAA Requirement
The HIPAA Privacy, Security, and Breach Notification Rules Regulated Entities to meet specific standards to protect the privacy and security of protected health information. Since the HIPAA Security Rule first took effect, risk analysis is one of the four required implementation specifications Regulated Entities must meet under the Security Management Process standard in 45 CFR § 164.308.
To fulfill this Risk Analysis requirement, a Regulated Entity must conduct an “accurate and thorough assessment of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of ePHI” and “[i]mplement policies and procedures to prevent, detect, contain, and correct security violations.”
Additionally, in 45 CFR § 164.402 the HIPAA Breach Notification Rule requires a Regulated Entity that experiences an impermissible acquisition, access, use, or disclosure (“breach”) of unsecured ePHI to conduct a documented risk assessment to determine whether the Regulated Entity must notify affected individuals, OCR and in the case of breaches involving the ePHI of 500 or more individuals, the media. As consistently interpreted and applied by OCR, experiencing a breach or the existence of evidence putting the Regulated Entity on notice of a potential susceptibility creating a risk of a breach triggers a duty by the Regulated Entity to conduct a Risk Assessment to assess the susceptibility of its ePHI to the risk and the actions reasonably necessary to mitigate it under the Security Rule.
OCR views Risk Analysis as foundational to the protection of ePHI. As OCR Acting Director Anthony Archeval recently stated to explain OCR’s emphasis on Risk Analysis compliance and enforcement, “Ransomware and hacking are the primary cyber-threats to electronic protected health information within the health care industry. Failure to conduct a HIPAA risk analysis puts this information at risk and vulnerable to future ransomware attacks and other cyber-threats[.]” Consequently, OCR has constantly has urged Regulated Entities to fulfill their Risk Analysis obligations since the earliest days of HIPAA. To promote compliance, OCR persistently has communicated the necessity and importance of the Risk Analysis in guidance and sought to reinforce the consequences of inadequate Risk Analysis by discussing the role of Risk Analysis deficiencies in creating the circumstances leading to enforcement actions against Regulated Entitles in its civil monetary penalty assessments and HIPAA settlement announcements.
Despite OCR’s constant and ever-rising efforts to promote compliance with the Risk Analysis requirements, however, OCR consistently has found deficiencies in Regulated Entities’ Risk Analysis in its breach investigations and audit findings since these rules became effective. As the number and magnitude of reported breaches of ePHI skyrocketing and massive breaches like those experienced in 2024 by UnitedHealthcare subsidiary Change Health, Ascension and others demonstrating the serious consequences ransomware and other cyberattacks can inflict on health plan claims and payment, health care delivery, payment, and patient privacy, OCR is placing new emphasis on tightening both the requirements for Risk Analysis and its enforcement of compliance with the Risk Analysis requirements.
On December 27, 2024, for instance, OCR published a notice of proposed rulemaking that proposes to clarify and tighten significantly the Risk Analysis requirements and other elements of the HIPAA Security Rule. Along with proposing these heightened Risk Analysis requirements, OCR announced and now is zealously enforcing the current Risk Analysis requirements through its Risk Analysis Initiative to hold Regulated Entities accountable for failing to fulfill their Risk Analysis responsibilities as part of its heightened efforts to improve Regulated Entities’ fulfillment of their Risk Analysis obligations. With OCR’s announcement of the NERAD and GMHA enforcement actions on April 10 and April 17, respectively bringing to seven the number of Risk Analysis Initiative enforcement settlements in recent months, health care providers and other Regulated Entities should heed the schooling these and other similarly sanctioned organizations as a call to action to ensure their own Risk Analysis and other HIPAA Privacy, Security and Breach Rule compliance.
The first of two Risk Analysis Initiative settlements announced in seven days in April and the sixth enforcement action and settlement specifically labeled as taken under the “Risk Analysis Initiative,” the NERAD enforcement action and settlement announced April 10, 2025 resolves liabilities for violation of the Risk Analysis Rule arising from OCR’s investigation of a breach of ePHI stored on NERAD’s Picture Archiving and Communication System (“PACS”) server for storing, retrieving, managing, and accessing radiology images.
OCR initiated its investigation of NERAD after receiving a NERAD breach report that between April 2019 and January 2020, unauthorized individuals accessed radiology images stored on NERAD’s PACS server. NERAD notified the 298,532 patients whose information was potentially accessible on the PACS server of this breach. OCR’s investigation found that NERAD had failed to conduct an accurate and thorough Risk Analysis to determine the potential risks and vulnerabilities to the ePHI in NERAD’s information systems.
To avoid potentially much greater HIPAA civil monetary penalties under the terms of the resolution agreement, NERAD paid OCR $350,000 and agreed to implement a corrective action plan that OCR will monitor for two years. Under the corrective action plan, NERAD will take steps to improve its compliance with the HIPAA Security Rule and protect the security of ePHI, including:
Conducting an accurate and thorough Risk Analysis to determine the potential risks and vulnerabilities to the confidentiality, integrity, and availability of its ePHI;
Developing and implementing a risk management plan to address and mitigate security risks and vulnerabilities identified in its Risk Analysis;
Developing and implementing a written process to regularly review records of information system activity, such as audit logs, access reports, and security incident tracking reports;
Developing, maintaining, and revising, as necessary, its written policies and procedures to comply with the HIPAA Rules; and
Augmenting its existing HIPAA and security training program to all of its workforce members who have access to PHI.
Seven days after announcing the NERAD Risk Analysis enforcement action and settlement, OCR reaffirmed its commitment to enforcement of the Risk Analysis enforcement when it announced its first HIPAA settlement under the new Trump Administration with GMHA, a public hospital on the U.S. Territory, island of Guam, on April 17, 2025.
The seventh Risk Analysis Initiative enforcement action and eleventh ransomware enforcement action announced by OCR, the GMHA settlement arose from OCR’s investigation of two complaints alleging that GMHA impermissibly allowed the disclosure of ePHI of GMHA patients. OCR originally initiated its investigation in response to a January 2019 complaint alleging that GMHA experienced a ransomware attack affecting the ePHI of approximately 5,000 individuals. During the investigation, OCR received another complaint in March 2023 alleging that hackers accessed patient records. OCR’s investigation determined that GMHA had failed to conduct an accurate and thorough risk analysis to determine the potential risks and vulnerabilities to ePHI held by GMHA.
Under the terms of the resolution agreement, GMHA paid OCR $25,000 and agreed to implement a corrective action plan that OCR will monitor for three years. In the corrective action plan, GMHA must take a number of steps to ensure compliance with the HIPAA Security Rule and protect the security of ePHI, including:
Conduct an accurate and thorough risk analysis to determine the potential risks and vulnerabilities to the confidentiality, integrity, and availability of its ePHI;
Develop and implement a risk management plan to address and mitigate security risks and vulnerabilities identified in its risk analysis;
Develop a written process to regularly review records of information system activity, such as audit logs, access reports, and security incident tracking reports;
Develop, maintain, and revise, as necessary, written policies and procedures to comply with the HIPAA Privacy, Security and Breach Notification Rules;
Augment its existing HIPAA and security training program so all workforce members with access to PHI understand the HIPAA requirements and GMHA’s HIPAA policies and procedures;
Enhance workforce security and information access management by reviewing all access credentials that have been granted access to ePHI; and
Conduct breach risk assessments and provide evidence to OCR that all breach notification obligations have been conducted.
Required & Recommended Actions To Promote Defensibility Of Risk Analysis Compliance
With cyberattacks targeting health plan and other Regulated Entities soaring and OCR stepping up its scrutiny of Regulated Entities’ Risk Analysis compliance in audits and enforcement actions, each health plan and insurer and other Regulated Entity should review and tighten its Risk Analysis practices and documentation to reduce its susceptibility to potential breaches and to promote its ability to defend its compliance with the Risk Analysis requirements in the event of a breach investigation or audit.
Fulfill Current Risk Analysis Standards
To fulfill the “Risk Analysis” implantation specification, the Security Management Process Standard requires Regulated Entities enforce appropriate administrative, physical, and technical safeguards for the confidentiality, integrity, and security of electronic protected health information (“ePHI”) based on an up-to-date conduct of an up-to-date accurate and thorough assessment of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of ePHI held by that organization (“Risk Analysis”).
The Security Rule requires Regulated Entities to document each Risk Analysis in writing, to keep Risk Analysis documentation for six years, and to provide Risk Analysis documentation to OCR upon request.
Among other things, the Risk Analysis implementation standard requires regulated entities adequately to:
Identify where ePHI is located in the organization, including how ePHI enters, flows through, and leaves the organization’s information systems.
Integrate Risk Analysis and risk management into the organization’s business processes.
Ensure that audit controls are in place to record and examine information system activity.
Implement regular reviews of information system activity.
Utilize mechanisms to authenticate information to ensure only authorized users are accessing ePHI.
Encrypt ePHI in transit and at rest to guard against unauthorized access to ePHI when appropriate.
Incorporate lessons learned from incidents into the organization’s overall security management process.
Provide workforce members with regular HIPAA training that is specific to the organization and to the workforce members’ respective job duties.
Use Proposed Rules & Enforcement Actions For Additional Guidance To Mitigate Risks
The proposed rule published by OCR on December 27, 2024, seeks to clarify and expand the original requirements of the Risk Assessment implementation standard based on OCR’s past HIPAA Security and Breach Rule investigation and enforcement experience. Under the proposed rule, a Regulated Entity’s Risk Analysis also would be required to include:
Require the development and revision of a technology asset inventory and a network map that illustrates the movement of ePHI throughout the regulated entity’s electronic information system(s) on an ongoing basis, at least once every 12 months and in response to a change in the regulated entity’s environment or operations that may affect ePHI.
Require greater specificity for conducting a risk analysis, including a written assessment that contains, among other things:
A review of the technology asset inventory and network map;
Identification of all reasonably anticipated threats to the confidentiality, integrity, and availability of ePHI;
Identification of potential vulnerabilities and predisposing conditions to the regulated entity’s relevant electronic information systems;
An assessment of the risk level for each identified threat and vulnerability, based on the likelihood that each identified threat will exploit the identified vulnerabilities; and
A review of the technology asset inventory and network map.
Other changes included in the proposed rule would further heighten the Risk Analysis and other Security Standard requirements for Regulated Entities. For instance, the proposed rule would require Regulated Entities:
To establish written procedures to restore the loss of certain relevant electronic information systems and data within 72 hours;
To perform an analysis of the relative criticality of their relevant electronic information systems and technology assets to determine the priority for restoration;
To establish written security incident response plans and procedures documenting how workforce members are to report suspected or known security incidents and how the regulated entity will respond to suspected or known security incidents;
To implement written procedures for testing and revising written security incident response plans;
To conduct a compliance audit at least once every 12 months to ensure their compliance with the Security Rule requirements;
To require business associates to verify at least once every 12 months for covered entities (and that business associate contractors verify at least once every 12 months for business associates) that they have deployed technical safeguards required by the Security Rule to protect ePHI through a written analysis of the business associate’s relevant electronic information systems by a subject matter expert and a written certification that the analysis has been performed and is accurate;
To encrypt ePHI at rest and in transit, with limited exceptions;
To establish and deploy technical controls for configuring relevant electronic information systems, including workstations, in a consistent manner including deployment of anti-malware protection, removal of extraneous software, and disabling network ports in accordance with the regulated entity’s risk analysis;
Use of multi-factor authentication, with limited exceptions;
Vulnerability scanning at least every six months and penetration testing at least once every 12 months;
Network segmentation;
Separate technical controls for backup and recovery of ePHI and relevant electronic information systems;
To review and test the effectiveness of certain security measures at least once every 12 months, in place of the current general requirement to maintain security measures;
Business associates to notify covered entities (and subcontractors to notify business associates) upon activation of their contingency plans without unreasonable delay, but no later than 24 hours after activation;
Group health plans to include in their plan documents requirements for their group health plan sponsors to: comply with the administrative, physical, and technical safeguards of the Security Rule; ensure that any agent to whom they provide ePHI agrees to implement the administrative, physical, and technical safeguards of the Security Rule; and notify their group health plans upon activation of their contingency plans without unreasonable delay, but no later than 24 hours after activation.
To help Regulated Entities understand and fulfill these responsibilities, OCR alone and in conjunction with the Office of the National Coordinator for Health Information Technology (“ONC”) also has published guidance like the HIPAA Security Risk Assessment (SRA) Tool. OCR guidance reflects that fulfillment of the Tool can help Regulated Entities may help defend but does not guarantee fulfillment of the Risk Assessment requirements, as the adequacy of the Risk Assessment always depends upon the unique facts and circumstances of the Regulated Entity at a particular time. This guidance confirms the importance of conducting timely and appropriate Risk Analysis in a manner that shows the Regulated Entity appropriately evaluated the risks to its e-PHI and acted reasonably in designing, administering, and updating that Risk Analysis to reasonably defend its e-PHI against breaches or other susceptibilities.
Since OCR’s guidance makes clear that the adequacy of a Regulated Entity’s Risk Analysis and other HIPAA Security compliance based on its evaluation and response to known and suspected susceptibility threats as conducted and documented pursuant to the Risk Analysis rule, health plans and other Regulated Entities should view Risk Analysis as a ongoing process. While the Security Rule does not currently dictate how frequently a regulated entity must perform Risk Analysis, a proposed rule published by OCR on December 27, 2024 seeks to amend the existing Security Rule to expand the requirement to require regulated entities to develop and revise a technology asset inventory and a network map that illustrates the movement of ePHI throughout the regulated entity’s electronic information system(s) on an ongoing basis, at least once every 12 months and in response to a change in the regulated entity’s environment or operations that may affect ePHI. Although OCR has not yet officially adopted this and other changes contained in the proposed rule, substantial evidence exists that it already regularly administers the Risk Analysis requirement with the expectation that regulated entities will perform Risk Analysis at least this frequently. For instance, current OCR resolution agreements require impacted organizations to conduct Risk Analysis to identify and address vulnerabilities at least annually, and more frequently as needed in response to signs of potential breach or susceptibility. Likewise, since OCR developed the proposed rule from its past enforcement experience, wise Regulated Entities also will recognize the value of drawing upon the changes set forth in the proposed rule for helpful insights to strengthen the security of their ePHI generally and promoting the defensibility of the adequacy of their Risk Assessments.
Suggested Process For Updating & Strengthening Risk Analysis
With the continued explosion in ransomware and other cyberthreats heightening the risk of experiencing a breach or other incident likely to draw the attention of OCR, each health plan or other Regulated Entity should take assess and confirm the adequacy of their current Risk Analysis, both to protect its ePHI and to promote its ability to defend its compliance with the HIPAA Security Rule’s Risk Analysis and other requirements in light of OCR’s heightened emphasis on Risk Analysis compliance and enforcement. For purposes of conducting this analysis, Regulated Entities generally will want to use a process like the following to structure their evaluation of their existing Risk Analysis to take advantage of the opportunity to use attorney-client privilege and other evidentiary rules to help protect discoverability of sensitive discussions about possible deficiencies in their existing Risk Analysis and discussions about potential tradeoffs considered in current or future Risk Analysis response:
Engage legal counsel experienced with HIPAA and other cybersecurity-related risks and liabilities to advise and assist your organization in designing and administering your Risk Analysis processes and response within the scope of attorney-client privilege;
Appoint and designate leadership and technical leadership for team responsible for design and administration of your organization’s initial and ongoing cybersecurity Risk Analysis and response (“Cyber-Risk Team”) and process for board and senior management reporting of the Cyber-Risk Team;
Select and engage outside consulting service providers, cyber-liability insurers and other risk service providers expected to participate in the process; work with qualified legal counsel to contract with these business associates to include the business associate agreement and other reassurances required by the HIPAA Privacy, Security and Breach Notification Rule and other performances, cooperation to provide and back services in accordance with agreed-upon protocols in the contract;
Train Cyber-Risk Team in the appropriate processes for working with internal teams, outside service providers, leadership, and designated legal counsel to conduct Risk Analysis, investigation and response using attorney-client privilege and other evidentiary tools and processes to maximize defensibility;
Require the Cyber-Risk Team conduct an updated, document assessment of cyber-risk within scope of attorney-client privilege and work with legal counsel to develop a documented cyber-risk policy that captures analysis and determinations for your justification for the size, scope and timing of your periodic Risk Analysis and rules and processes for interim risk identification, reassessments and response in reaction to potential cyber-risk signs between periodic Risk Analysis for presentation and approval by the Board taking into account the insights from published final and proposed guidance, enforcement actions and industry standards;
Require, oversee and enforce Cyber-Risk Team’s documented administration of the initial and subsequently required Risk Analysis and response pursuant to the adopted cyber-risk policy to identify vulnerabilities and work with legal counsel within the scope of privilege to document your analysis and justifications for addressing identified vulnerabilities and other required actions in response to identified susceptibilities or event;
Review adequacy of incident detection and response arrangements, including reporting and response mechanisms, insurance and indemnification protection, and other critical elements for mitigation and recovery; and
Other actions as warranted based on advice of counsel taking into account emerging threats, guidance, and risk susceptibility.
Although civil monetary penalties or settlements are the most common sanction imposed for HIPAA Security and Breach Notification rule violations, willful and certain other violations of HIPAA can trigger criminal liability subject to the Federal Sentencing Guidelines. Consequently, beyond fulfilling the specific requirements of HIPAA, an adequate Risk Assessment also can be an invaluable tool for helping mitigate Federal Sentencing Guideline exposures of a Regulated Entity and its leaders under the Federal Sentencing Guidelines Organizational Liability rules.
Beyond these specific HIPAA-associated exposures, Regulated Entities and their leaders should keep in mind that HIPAA is likely only one of many laws that define their responsibilities to secure, report, and respond to breaches of ePHI or other sensitive data. Depending on the location, nature and other circumstances, Regulated Entities and their leaders also may have additional responsibilities and liability exposures under a variety of other federal and state laws, ethical or other professional standards, and contractual obligations. For instance, health plan fiduciaries may risk fiduciary liability under the Employee Retirement Income Security Act of 1974 for failing to prudently secure and protect participate and other health plan data from improper access, use or disclosure. Inadequate data safeguards for ePHI also can trigger liability for brokers, consultants, insurers and others under the Fair and Accurate Credit Transactions Act, the Federal Trade Commission Act, and various electronic crimes statutes. The Securities and Exchange Commission rules can trigger disclosure and other obligations for publicly traded employers and insurers. Regulated Entities and their leaders generally will want to fully evaluate and manage these risks in conjunction with their compliance with the Risk Analysis and other requirements of the HIPAA Security and Breach Notification Rules.
The author of this update, Cynthia Marcotte Stamer is nationally known and celebrated for her experience providing advice and representation to employers, employer and other health plan sponsors, health plans, health plan fiduciaries and administrators, third party administrators, health care and life sciences organizations, human resources and health plan technology, and other businesses about HIPAA and other compliance, risk management and operational matters. If you have questions or need advice or help evaluating or addressing these or other compliance, risk management, or other concerns, contact her.
For More Information
We hope this update is helpful. For more information about these or other health or other employee benefits, human resources, or health care developments, please contact the author, Cynthia Marcotte Stamer, via e-mail or telephone at (214) 452-8297.
Solutions Law Press, Inc. invites you to receive future updates by registering on our Solutions Law Press, Inc. Website and participating and contributing to the discussions in our Solutions Law Press, Inc. LinkedIn SLP Health Care Risk Management & Operations Group, HR & Benefits Update Compliance Group, and/or Coalition for Responsible Health Care Policy.
About the Author
Cynthia Marcotte Stamer is a Martindale-Hubble AV-Preeminent (highest/top 1%) practicing attorney recognized as a “Top Woman Lawyer,” “Top Rated Lawyer,” and “LEGAL LEADER™” in Health Care Law and Labor and Employment Law; among the “Best Lawyers In Dallas” in “Labor & Employment,” “Tax: ERISA & Employee Benefits,” “Health Care” and “Business and Commercial Law recognized for her experience, scholarship, thought leadership and advocacy on HIPAA and other data and technology use, security and compliance in connection with her work with health care and life sciences, employee benefits, insurance, education, technology and other highly regulated and performance-dependent clients.
Board certified in labor and employment law by the Texas Board of Legal Specialization and a Fellow in the American College of Employee Benefits Counsel, Ms. Stamer works with these and other highly regulated or data and performance reliant businesses to design, risk manage, and defend their employment and other workforce, data and technology and other operations to promote legal and operational compliance, reduce regulatory and other liability and promote other operational goals.
Along with her decades of legal and strategic consulting experience, Ms. Stamer also contributes her leadership and experience to many professional, civic and community organizations. She currently serves as Co-Chair of the ABA Real Property Trusts and Estates (“RPTE”) Section Welfare Plan Committee, Co-Chair of the ABA International Section International Employment Law Committee and its Annual Meeting Program Planning Committee, Chair Emeritus and Vice Chair of the ABA Tort Trial and Insurance (“TIPS”) Section Medicine and Law Committee, and Chair of the ABA Intellectual Property Section Law Practice Management Committee.
Additionally,more her ABA involvements include than a decade of service as a Scribe for the Joint Committee on Employee Benefits (“JCEB”) annual agency meetings with the Department of Health and Human Services and JCEB Council Representative, International Section Life Sciences Committee Chair, RPTE Section Employee Benefits Group Chair and a Substantive Groups Committee Member, Health Law Section Managed Care & Insurance Interest Group Chair, as TIPS Section Medicine and Law Committee Chair and Employee Benefits Committee and Workers Compensation Committee Vice Chair, Tax Section Fringe Benefit Committee Chair, and in various other ABA leadership capacities. Ms. Stamer also is a former Southwest Benefits Association Board Member and Continuing Education Chair, SHRM National Consultant Board Chair and Region IV Chair, Dallas Bar Association Employee Benefits Committee Chair, former Texas Association of Business State, Regional and Dallas Chapter Chair, a founding board member and Past President of the Alliance for Healthcare Excellence, as well as in the leadership of many other professional, civic and community organizations. She also is recognized for her contributions to strengthening health care policy and charitable and community service resolving health care challenges performed under PROJECT COPE Coalition For Patient Empowerment initiative and many other pro bono service involvements locally, nationally and internationally.
Ms. Stamer is the author of many highly regarded works published by leading professional and business publishers, the ABA, the American Health Lawyers Association, and others. Ms. Stamer also frequently speaks and serves on the faculty and steering committee for many ABA and other professional and industry conferences and conducts leadership and industry training for a wide range of organizations.
For more information about Ms. Stamer or her health industry and other experience and involvements, see http://www.cynthiastamer.com or contact Ms. Stamer via telephone at (214) 452-8297 or via e-mail here.
About Solutions Law Press™
Solutions Law Press™ provides health care, insurance, human resources and employee benefit, data and technology, regulatory and operational performance, and other business risk management, legal compliance, management effectiveness and other coaching, tools and other resources, training and education. These include extensive resources on leadership, governance, human resources, employee benefits, data security and privacy, insurance, health care and other key compliance, risk management, internal controls and operational concerns. If you find this of interest, you also be interested reviewing some of our other Solutions Law Press™ resources or training.
If you or someone else you know would like to receive future updates about developments on these and other concerns, please be sure that we have your current contact information including your preferred e-mail by creating your profile here.
NOTICE: These statements and materials are for general information and purposes only. They do not establish an attorney-client relationship, are not legal advice or an offer or commitment to provide legal advice, and do not serve as a substitute for legal advice. Readers are urged to engage competent legal counsel for consultation and representation considering the specific facts and circumstances presented in their unique circumstances at the particular time. No comment or statement in this publication is to be construed as legal advice or an admission. Solutions Law Press and its authors reserve the right to qualify or retract any of these statements at any time. Likewise, the content is not tailored to any particular situation and does not necessarily address all relevant issues. Because the law constantly and often rapidly evolves, subsequent developments that could impact the currency and completeness of this discussion are likely. Solutions Law Press and its authors disclaim and have no responsibility to provide any update or otherwise notify anyone of any fact or law-specific nuance, change, limitation, or other condition that might affect the suitability of reliance upon these materials or information otherwise conveyed in connection with this program. Readers may not rely upon, are solely responsible for, and assume the risk and all liabilities resulting from their use of this publication.
Circular 230 Compliance. The following disclaimer is included to ensure that we comply with U.S. Treasury Department Regulations. Any statements contained herein are not intended or written by the writer to be used, and nothing contained herein can be used by you or any other person, for the purpose of (1) avoiding penalties that may be imposed under federal tax law, or (2) promoting, marketing or recommending to another party any tax-related transaction or matter addressed herein.
Creating greater transparency of the compensation of prescription benefit management (“PBM”) arrangements used in group health plans covered by the Employee Retirement Income Security Act of 1974 (“ERISA”) is one of many new policy directives President Trump directs federal agencies to pursue to promote lower cost access to prescription drugs under his Executive Order on Lowering Drug Prices By Once Again Putting Americans First (the “Executive Order”) signed April 15, 2025. Employer and union-sponsored health plans, their sponsors, fiduciaries and service providers should carefully track and provide appropriate input to the Department of Labor and other federal agencies charged with implementing the new ERISA transparency requirement and other policy changes directed in the Executive Order.
ERISA PMB Transparency Requirements
To improve the transparency of compensation received by PBMs working with ERISA-covered group health plnas, the Executive Order directs the Department of Labor (“DOL”) to propose regulations to make the fee disclosure requirements of ERISA section 408(b)(2)(B) applicable to PBMs by October 12, 2025.
The Executive Order’s directive to the DOL contemplates that DOL will revise its existing regulations under Section 408(b)(2) to prohibit group health plan fiduciaries from allowing PBMs to directly or indirectly receive compensation for their PBM services unless the PBM discloses its compensation from the arrangement in accordace with the fee disclosure requirements that the Executive Order contemplates DOL will add to ERISA section 408(b)(2).
While DOL regulations have required since 2012 that pension plan service providers to disclose direct or indirect compensation under arrangements with ERISA-covered pension plans in order for the service provider compensation to be allowed “reasonable compensation” under ERISA section 408(b)(2), the fee disclosure requirement currently does not apply to PBMs or other service providers to group health plans or other welfare benefit plan arrangements.
Across the intervening years, concern that the lack of transparency and disclosure allows PBMs to receive excessive compensation and engage in conflicts of interest has led employee benefit industry watchdogs, employer and other plan sponsors, plan members, health care providers and others increasingly to urge the DOL to impose fee disclosure requirements on PBMs and other health and welfare benefit plan service providers. The Executive Order yields to these demands by calling upon the DOL to deem a group health plan’s compensation arrangements with PBMs reasonable only where PBMs disclose direct and indirect compensation, including compensation paid among related parties such as subcontractors, in a manner consistent with current Section 408(b )(2) Regulations.
Other Prescription Drug Reforms
The Executive Order also includes numerous other reform directives beyond calling for DOL to make PBMs subject to ERISA’s fee disclosure rules. These included several directives to HHS and certain other agencies that President Trump intends to lower the cost of prescription drugs within and outside the Medicare program.
Medicare & Other Drug Pricing and Coverage Related Prescription Drug Reforms
Many of the policy directives in the Executive Order seek to reform Medicare and other prescription drug cost and coverage.
By April 15, 2026, for instance, the Executive Order directs HHS to develop a better payment model to improve the ability of the Medicare program to obtain better value for high-cost prescription drugs and biological products covered by Medicare, including those not subject to the Medicare Drug Price Negotiation Program.
In addition, the Executive Order:
Directs HHS to work with the Congress to modify the Medicare Drug Price Negotiation Program to align the treatment of small molecule prescription drugs with that of biological products so as to end the distortion that undermines relative investment in small molecule prescription drugs, coupled with other reforms to prevent any increase in overall costs to Medicare and its beneficiaries;
By June 14, 2025,
Requires HHS to propose changes to the Medicare Drug Price Negotiation Program regulations for the initial price applicability year 2028 and manufacturer implementation of maximum fair price under such program in 2026, 2027, and 2028 to improve the transparency of the Medicare Drug Price Negotiation Program, prioritize the selection of prescription drugs with high costs to the Medicare program, and minimize any negative impacts of the maximum fair price on pharmaceutical innovation within the United States; andRequires HHS to require health centers receiving Public Health Service Act Section 330(e) grants to establish practices to make insulin and injectable epinephrine available at or below the discounted price paid by the health center grantee or sub-grantee under the 340B Prescription Drug Program (plus a minimal administration fee) to low income individuals who have a high cost-sharing requirement for either insulin or injectable epinephrine; have a high unmet deductible; or have no healthcare insurance.Requires the Assistant to the President for Domestic Policy (“APDP”) in coordination with the Secretary, the Director of the Office of Management and Budget (“OMB Director”), and the Assistant to the President for Economic Policy (“APECP”), to provide recommendations to the President on how best to stabilize and reduce Medicare Part D premiums;Requires the HHS Secretary to publish a plan to conduct a survey under the Site-of-Service Price Transparency rules of Social Security Act Section 1833(t)(14)(D)(ii) to determine the hospital acquisition cost for covered outpatient drugs at hospital outpatient departments and propose appropriate adjustments to align Medicare payment with the cost of acquisition, consistent with the budget neutrality requirements; and
Requires HHS to evaluate and propose regulations to ensure that payment within the Medicare program is not encouraging a shift in drug administration volume away from less costly physician office settings to more expensive hospital outpatient departments.
Other Prescription Drug Reforms
In addition to these predominantly Medicare-focused programs, the Executive Order also orders federal agencies to
Requires the Secretary of Labor to propose regulations pursuant to section 408(b)(2)(B) of the Employee Retirement Income Security Act of 1974 to improve employer health plan fiduciary transparency into the direct and indirect compensation received by pharmacy benefit managers by October 12, 2025;
Requires the APDP, in coordination with the HHS Secretary, the OMB Director, and the APECP, to provide recommendations to the President on how best to promote a more competitive, efficient, transparent, and resilient pharmaceutical value chain that delivers lower drug prices for Americans by June 14, 2025;
Requires the Food and Drug Administration to streamline and improve the Importation Program under the Federal Food, Drug, and Cosmetic Act to make it easier for States to obtain approval without sacrificing safety or quality;
Requires the OMB Director, the APDP, and the Assistant to the President for Economic Policy )”APECP, and HHS Secretary to provide joint recommendations on how best to ensure that manufacturers pay accurate Medicaid drug rebates consistent with section 1927 of the Social Security Act, promote innovation in Medicaid drug payment methodologies, link payments for drugs to the value obtained, and support States in managing drug spending;
Requires the HHS Secretary, through the Commissioner of Food and Drugs, to issue a report providing administrative and legislative recommendations to accelerate approval of generics, biosimilars, combination products, and second-in-class brand name medications; and improve the process through which prescription drugs can be reclassified as over-the-counter medications, including recommendations to optimally identify prescription drugs that can be safely provided to patients over the counter;
Requires HHS, the Department of Justice, the Department of Commerce, and the Federal Trade Commission to conduct listening sessions and issue a report with recommendations to reduce anti-competitive behavior from pharmaceutical manufacturers.
Health plans, their sponsoring employers or unions, fiduciaries, PBM and other service providers, brokers, insurers, auditors, and others involved in the design or oversight of PBM and other group health plan arrangements should monitor closely the DOL and other agency responses to the Executive Order to anticipate and prepare for required changes, as well as to be prepared to identify and timely provide input about proposed rules or other actions to DOL or the otherwise applicable regulatory agency before finalized.
The author of this update, Cynthia Marcotte Stamer is an American College of Employee Benefits Counsel Fellow and attorney board certified in Labor and Employment Law by the Texas Board of Legal Specialization, with decades of experience advising employers and other health plan sponsors, health plans, health plan fiduciaries and administrators, PBMs, health and other insurers, third party administrators, managed care organizations, health plan technology, and other businesses about health plan design, administration, and other compliance, risk management and operational matters. If you have questions or need advice or help evaluating or addressing these or other compliance, risk management, or other concerns, contact her.
For More Information
We hope this update is helpful. For more information about these or other health or other employee benefits, human resources, or health care developments, please contact the author, Cynthia Marcotte Stamer, via e-mail or telephone at (214) 452-8297.
Solutions Law Press, Inc. invites you to receive future updates by registering on our Solutions Law Press, Inc. Website and participating and contributing to the discussions in our Solutions Law Press, Inc. LinkedIn SLP Health Care Risk Management & Operations Group, HR & Benefits Update Compliance Group, and/or Coalition for Responsible Health Care Policy.
About the Author
A Fellow in the American College of Employee Benefit Counsel, the American Bar Foundation and the Texas Bar Foundation; Cynthia Marcotte Stamer is an attorney board certified in labor and employment law by the Texas Board of Legal Specialization, management consultant, author, public policy advocate and lecturer sought out by clients and industry and government leaders for her more than 35 years of health, insurance, employment and employee benefits and other industry management work, thought leadership, public policy and regulatory affairs advocacy, coaching, teaching, and publications on health and other employee benefits, health care, insurance, workforce and other risk management and compliance.
Along with her decades of legal and strategic consulting experience, Ms. Stamer also contributes her leadership and experience to many professional, civic and community organizations. Along with currently serving as Co-Chair of the ABA Real Property Trusts and Estates (“RPTE”) Section Welfare Plan Committee, Co-Chair of the ABA International Section International Employment Law Committee and its Annual Meeting Program Planning Committee, Chair Emeritus and Vice Chair of the ABA Tort Trial and Insurance (“TIPS”) Section Medicine and Law Committee, and Chair of the ABA Intellectual Property Section Law Practice Management Committee, her previous ABA leadership roles include more than a decade of service as a Scribe for the Joint Committee on Employee Benefits (“JCEB”) annual agency meetings with the Department of Health and Human Services and JCEB Council Representative, International Section Life Sciences Committee Chair, RPTE Section Employee Benefits Group Chair and a Substantive Groups Committee Member, Health Law Section Managed Care & Insurance Interest Group Chair, as TIPS Section Medicine and Law Committee Chair and Employee Benefits Committee and Workers Compensation Committee Vice Chair, Tax Section Fringe Benefit Committee Chair, and in various other ABA leadership capacities. Ms. Stamer also is a former Southwest Benefits Association Board Member and Continuing Education Chair, SHRM National Consultant Board Chair and Region IV Chair, Dallas Bar Association Employee Benefits Committee Chair, former Texas Association of Business State, Regional and Dallas Chapter Chair, a founding board member and Past President of the Alliance for Healthcare Excellence, as well as in the leadership of many other professional, civic and community organizations. She also is recognized for her contributions to strengthening health care policy and charitable and community service resolving health care challenges performed under PROJECT COPE Coalition For Patient Empowerment initiative and many other pro bono service involvements locally, nationally and internationally.
Ms. Stamer is the author of many highly regarded works published by leading professional and business publishers, the ABA, the American Health Lawyers Association, and others. Ms. Stamer also frequently speaks and serves on the faculty and steering committee for many ABA and other professional and industry conferences and conducts leadership and industry training for a wide range of organizations.
For more information about Ms. Stamer or her health industry and other experience and involvements, see http://www.cynthiastamer.com or contact Ms. Stamer via telephone at (214) 452-8297 or via e-mail here.
About Solutions Law Press™
Solutions Law Press™ provides health care, insurance, human resources and employee benefit, data and technology, regulatory and operational performance, and other business risk management, legal compliance, management effectiveness and other coaching, tools and other resources, training and education. These include extensive resources on leadership, governance, human resources, employee benefits, data security and privacy, insurance, health care and other key compliance, risk management, internal controls and operational concerns. If you find this of interest, you also be interested reviewing some of our other Solutions Law Press™ resources or training.
If you or someone else you know would like to receive future updates about developments on these and other concerns, please be sure that we have your current contact information including your preferred e-mail by creating your profile here.
NOTICE: These statements and materials are for general information and purposes only. They do not establish an attorney-client relationship, are not legal advice or an offer or commitment to provide legal advice, and do not serve as a substitute for legal advice. Readers are urged to engage competent legal counsel for consultation and representation considering the specific facts and circumstances presented in their unique circumstances at the particular time. No comment or statement in this publication is to be construed as legal advice or an admission. Solutions Law Press and its authors reserve the right to qualify or retract any of these statements at any time. Likewise, the content is not tailored to any particular situation and does not necessarily address all relevant issues. Because the law constantly and often rapidly evolves, subsequent developments that could impact the currency and completeness of this discussion are likely. Solutions Law Press and its authors disclaim and have no responsibility to provide any update or otherwise notify anyone of any fact or law-specific nuance, change, limitation, or other condition that might affect the suitability of reliance upon these materials or information otherwise conveyed in connection with this program. Readers may not rely upon, are solely responsible for, and assume the risk and all liabilities resulting from their use of this publication.
Circular 230 Compliance. The following disclaimer is included to ensure that we comply with U.S. Treasury Department Regulations. Any statements contained herein are not intended or written by the writer to be used, and nothing contained herein can be used by you or any other person, for the purpose of (1) avoiding penalties that may be imposed under federal tax law, or (2) promoting, marketing or recommending to another party any tax-related transaction or matter addressed herein.
The $350,000 paid by Northeast Radiology, P.C. (“NERAD”) provides the latest warning to health plans, health care providers, healthcare clearinghouses (“Covered Entities”) and their business associates (collectively “Regulated Entities”) they risk costly fines and other costs for failing to maintain the up-to-date risk assessments required by the Health Insurance Portability & Accountability Act (“HIPAA”).
Following up on the five other previous Risk Analysis Initiative enforcement actions and settlements recently announced by the U.S. Department of Health and Human Services (“HHS”) Office for Civil Rights (“OCR”) and OCR’s publication of proposed rules to significantly tighten HIPAA’s Risk Analysis and other requirements, the settlement with medical imaging center NERAD sends a strong warning to health plans and other Regulated Entities to clean up and strengthen their Risk Analysis and other HIPAA Security Rule compliance.
$350,000 NERAD Risk Analysis Settlement Latest Product Of New Enforcement Initiative
The sixth Risk Analysis Initiative enforcement action announced by OCR in recent months, the NERAD settlement resolves an OCR Risk Analysis Initiative enforcement action arising from OCR’s investigation of a breach of ePHI stored on NERAD’s Picture Archiving and Communication System (“PACS”) server for storing, retrieving, managing, and accessing radiology images.
OCR initiated its investigation of NERAD after receiving a NERAD breach report about a breach of unsecured ePHI in March 2020. NERAD reported that between April 2019 and January 2020, unauthorized individuals accessed radiology images stored on NERAD’s PACS server. NERAD notified the 298,532 patients whose information was potentially accessible on the PACS server of this breach. OCR’s investigation found that NERAD had failed to conduct an accurate and thorough Risk Analysis to determine the potential risks and vulnerabilities to the ePHI in NERAD’s information systems.
To avoid potentially much greater HIPAA civil monetary penalties under the terms of the resolution agreement, NERAD paid OCR $350,000 and agreed to implement a corrective action plan that OCR will monitor for two years. Under the corrective action plan, NERAD will take steps to improve its compliance with the HIPAA Security Rule and protect the security of ePHI, including:
Conducting an accurate and thorough Risk Analysis to determine the potential risks and vulnerabilities to the confidentiality, integrity, and availability of its ePHI;
Developing and implementing a risk management plan to address and mitigate security risks and vulnerabilities identified in its Risk Analysis;
Developing and implementing a written process to regularly review records of information system activity, such as audit logs, access reports, and security incident tracking reports;
Developing, maintaining, and revising, as necessary, its written policies and procedures to comply with the HIPAA Rules; and
Augmenting its existing HIPAA and security training program to all of its workforce members who have access to PHI.
OCR Turns Up Heat On HIPAA Risk Analysis Requirements & Enforcement
The HIPAA Privacy, Security, and Breach Notification Rules set forth the requirements that Regulated Entities must follow to protect the privacy and security of protected health information. Since the HIPAA Security Rule first took effect, risk analysis is one of the four required implementation specifications the Security Rule requires to fulfill its Security Management Process Standard’s requirement that regulated entities “[i]mplement policies and procedures to prevent, detect, contain, and correct security violations.”
Written Risk Analysis Longstanding Requirement
Although OCR only recently formally adopted a Risk Analysis Initiative, OCR’s regulatory guidance and enforcement actions have communicated clearly the necessity for each Regulated Entity to possess and maintain an adequate documented Risk Analysis. OCR guidance since has required Regulated Entities to conduct and document the required Risk Analysis to safeguard ePHI and avoid liability under the HIPAA Rule. The importance of fulfillment of the Risk Analysis requirement is driven home by OCR’s recent identification of Risk Analysis inadequacies as a basis for its assessment of civil monetary penalties or required resolution payments to settle HIPAA Security Rule violations following a breach of ePHI.
While the Security Rule does not currently dictate how frequently a regulated entity must perform Risk Analysis, a proposed rule published by OCR on December 27, 2024 seeks to amend the existing Security Rule to expand the requirement to require regulated entities to develop and revise a technology asset inventory and a network map that illustrates the movement of ePHI throughout the regulated entity’s electronic information system(s) on an ongoing basis, at least once every 12 months and in response to a change in the regulated entity’s environment or operations that may affect ePHI. Although OCR has not adopted this and other changes contained in the proposed rule, substantial evidence exists that it already regularly administers the Risk Analysis requirement with the expectation that regulated entities will perform Risk Analysis at least this frequently. For instance, current OCR resolution agreements require impacted organizations to conduct Risk Analysis to identify and address vulnerabilities at least annually, and more frequently as needed in response to signs of potential breach or susceptibility.
To fulfill the “Risk Analysis” implantation specification, the Security Management Process Standard requires Regulated Entities maintain appropriate administrative, physical, and technical safeguards for the confidentiality, integrity, and security of electronic protected health information (“ePHI”) based on an up-to-date conduct of an up-to-date accurate and thorough assessment of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of ePHI held by that organization (“Risk Analysis”).
The Security Rule requires Regulated Entities to document each Risk Analysis in writing, to maintain their Risk Analysis documentation for six years, and to make available Risk Analysis documentation to OCR upon request.
Among other things, the Risk Analysis implementation standard requires regulated entities adequately to:
Identify where ePHI is located in the organization, including how ePHI enters, flows through, and leaves the organization’s information systems.
Integrate Risk Analysis and risk management into the organization’s business processes.
Ensure that audit controls are in place to record and examine information system activity.
Implement regular reviews of information system activity.
Utilize mechanisms to authenticate information to ensure only authorized users are accessing ePHI.
Encrypt ePHI in transit and at rest to guard against unauthorized access to ePHI when appropriate.
Incorporate lessons learned from incidents into the organization’s overall security management process.
Provide workforce members with regular HIPAA training that is specific to the organization and to the workforce members’ respective job duties.
OCR Heightens Risk Analysis Enforcement While Proposing Heightened Risk Analysis And Other Security Requirements
The proposed rule published by OCR on December 27, 2024 seeks to significantly broaden these original requirements of the Risk Assessment implementation standard. Under the proposed rule, a Regulated Entity’s Risk Analysis also would be required to include:
Require the development and revision of a technology asset inventory and a network map that illustrates the movement of ePHI throughout the regulated entity’s electronic information system(s) on an ongoing basis, at least once every 12 months and in response to a change in the regulated entity’s environment or operations that may affect ePHI.
Require greater specificity for conducting a risk analysis, including a written assessment that contains, among other things:
A review of the technology asset inventory and network map;
Identification of all reasonably anticipated threats to the confidentiality, integrity, and availability of ePHI;
Identification of potential vulnerabilities and predisposing conditions to the regulated entity’s relevant electronic information systems;
An assessment of the risk level for each identified threat and vulnerability, based on the likelihood that each identified threat will exploit the identified vulnerabilities; and
A review of the technology asset inventory and network map.
Other changes included in the proposed rule would further heighten the Risk Analysis and other Security Standard requirements for Regulated Entities. For instance, the proposed rule would require Regulated Entities:
To establish written procedures to restore the loss of certain relevant electronic information systems and data within 72 hours;
To perform an analysis of the relative criticality of their relevant electronic information systems and technology assets to determine the priority for restoration;
To establish written security incident response plans and procedures documenting how workforce members are to report suspected or known security incidents and how the regulated entity will respond to suspected or known security incidents;
To implement written procedures for testing and revising written security incident response plans;
To conduct a compliance audit at least once every 12 months to ensure their compliance with the Security Rule requirements;
To require business associates to verify at least once every 12 months for covered entities (and that business associate contractors verify at least once every 12 months for business associates) that they have deployed technical safeguards required by the Security Rule to protect ePHI through a written analysis of the business associate’s relevant electronic information systems by a subject matter expert and a written certification that the analysis has been performed and is accurate;
To encrypt ePHI at rest and in transit, with limited exceptions;
To establish and deploy technical controls for configuring relevant electronic information systems, including workstations, in a consistent manner including deployment of anti-malware protection, removal of extraneous software, and disabling network ports in accordance with the regulated entity’s risk analysis;
Use of multi-factor authentication, with limited exceptions;
Vulnerability scanning at least every six months and penetration testing at least once every 12 months;
Network segmentation;
Separate technical controls for backup and recovery of ePHI and relevant electronic information systems;
To review and test the effectiveness of certain security measures at least once every 12 months, in place of the current general requirement to maintain security measures;
Business associates to notify covered entities (and subcontractors to notify business associates) upon activation of their contingency plans without unreasonable delay, but no later than 24 hours after activation;
Group health plans to include in their plan documents requirements for their group health plan sponsors to: comply with the administrative, physical, and technical safeguards of the Security Rule; ensure that any agent to whom they provide ePHI agrees to implement the administrative, physical, and technical safeguards of the Security Rule; and notify their group health plans upon activation of their contingency plans without unreasonable delay, but no later than 24 hours after activation.
To help Regulated Entities understand and fulfill these responsibilities, OCR alone and in conjunction with the Office of the National Coordinator for Health Information Technology (“ONC”) also has published guidance like the HIPAA Security Risk Assessment (SRA) Tool. OCR guidance reflects that fulfillment of the Tool can help Regulated Entities may help defend but does not guarantee fulfillment of the Risk Assessment requirements, as the adequacy of the Risk Assessment always depends upon the unique facts and circumstances of the Regulated Entity at a particular time. This guidance confirms the importance of conducting timely and appropriate Risk Analysis in a manner that shows the Regulated Entity appropriately evaluated the risks to its e-PHI and acted reasonably in designing, administering, and updating that Risk Analysis to reasonably defend its e-PHI against breaches or other susceptibilities.
Recommended Actions For Health Plans & Other HIPAA-Regulated Entities
With the continued explosion in ransomware and other cyberthreats heightening the risk of experiencing a breach or other incident likely to draw the attention of OCR, each health plan or other Regulated Entity should take assess and confirm the adequacy of their current Risk Analysis, both to protect its ePHI and to promote its ability to defend its compliance with the HIPAA Security Rule’s Risk Analysis and other requirements in light of OCR’s heightened emphasis on Risk Analysis compliance and enforcement. For purposes of conducting this analysis, Regulated Entities generally will want to use a process like the following to structure their evaluation of their existing Risk Analysis to take advantage of the opportunity to use attorney-client privilege and other evidentiary rules to help protect discoverability of sensitive discussions about possible deficiencies in their existing Risk Analysis and discussions about potential tradeoffs considered in current or future Risk Analysis response:
Engage legal counsel experienced with HIPAA and other cybersecurity-related risks and liabilities to advise and assist your organization in designing and administering your Risk Analysis processes and response within the scope of attorney-client privilege;
Appoint and designate leadership and technical leadership for team responsible for design and administration of your organization’s initial and ongoing cybersecurity Risk Analysis and response (“Cyber-Risk Team”) and process for board and senior management reporting of the Cyber-Risk Team;
Select and engage outside consulting service providers, cyber-liability insurers and other risk service providers expected to participate in the process; work with qualified legal counsel to contract with these business associates to include the business associate agreement and other reassurances required by the HIPAA Privacy, Security and Breach Notification Rule and other performances, cooperation to provide and back services in accordance with agreed-upon protocols in the contract;
Train Cyber-Risk Team in the appropriate processes for working with internal teams, outside service providers, leadership, and designated legal counsel to conduct Risk Analysis, investigation and response using attorney-client privilege and other evidentiary tools and processes to maximize defensibility;
Require the Cyber-Risk Team conduct an updated, document assessment of cyber-risk within scope of attorney-client privilege and work with legal counsel to develop a documented cyber-risk policy that captures analysis and determinations for your justification for the size, scope and timing of your periodic Risk Analysis and rules and processes for interim risk identification, reassessments and response in reaction to potential cyber-risk signs between periodic Risk Analysis for presentation and approval by the Board taking into account the insights from published final and proposed guidance, enforcement actions and industry standards;
Require, oversee and enforce Cyber-Risk Team’s documented administration of the initial and subsequently required Risk Analysis and response pursuant to the adopted cyber-risk policy to identify vulnerabilities and work with legal counsel within the scope of privilege to document your analysis and justifications for addressing identified vulnerabilities and other required actions in response to identified susceptibilities or event;
Review adequacy of incident detection and response arrangements, including reporting and response mechanisms, insurance and indemnification protection, and other critical elements for mitigation and recovery; and
Other actions as warranted based on advice of counsel taking into account emerging threats, guidance, and risk susceptibility.
The author of this update, Cynthia Marcotte Stamer is an American College of Employee Benefits Counsel Fellow and attorney board certified in Labor and Employment Law by the Texas Board of Legal Specialization, nationally known and celebrated for her experience providing advice and representation on HIPAA and other risk management and compliance to employers and other health plan sponsors, health plans, health plan fiduciaries and administrators, health and other insurers, third party administrators, health care and other managed care providers and organizations, human resources and health plan technology, and other businesses about health plan design, administration, and other compliance, risk management and operational matters. If you have questions or need advice or help evaluating or addressing these or other compliance, risk management, or other concerns, contact her.
For More Information
We hope this update is helpful. For more information about these or other health or other employee benefits, human resources, or health care developments, please contact the author, Cynthia Marcotte Stamer, via e-mail or telephone at (214) 452-8297.
Solutions Law Press, Inc. invites you to receive future updates by registering on our Solutions Law Press, Inc. Website and participating and contributing to the discussions in our Solutions Law Press, Inc. LinkedIn SLP Health Care Risk Management & Operations Group, HR & Benefits Update Compliance Group, and/or Coalition for Responsible Health Care Policy.
About the Author
A Fellow in the American College of Employee Benefit Counsel, the American Bar Foundation and the Texas Bar Foundation; Cynthia Marcotte Stamer is an attorney board certified in labor and employment law by the Texas Board of Legal Specialization, management consultant, author, public policy advocate and lecturer sought out by clients and industry and government leaders for her more than 35 years of health, insurance, employment and employee benefits and other industry management work, thought leadership, public policy and regulatory affairs advocacy, coaching, teaching, and publications on health and other employee benefits, health care, insurance, workforce and other risk management and compliance.
Along with her decades of legal and strategic consulting experience, Ms. Stamer also contributes her leadership and experience to many professional, civic and community organizations. Along with currently serving as Co-Chair of the ABA Real Property Trusts and Estates (“RPTE”) Section Welfare Plan Committee, Co-Chair of the ABA International Section International Employment Law Committee and its Annual Meeting Program Planning Committee, Chair Emeritus and Vice Chair of the ABA Tort Trial and Insurance (“TIPS”) Section Medicine and Law Committee, and Chair of the ABA Intellectual Property Section Law Practice Management Committee, her previous ABA leadership roles include more than a decade of service as a Scribe for the Joint Committee on Employee Benefits (“JCEB”) annual agency meetings with the Department of Health and Human Services and JCEB Council Representative, International Section Life Sciences Committee Chair, RPTE Section Employee Benefits Group Chair and a Substantive Groups Committee Member, Health Law Section Managed Care & Insurance Interest Group Chair, as TIPS Section Medicine and Law Committee Chair and Employee Benefits Committee and Workers Compensation Committee Vice Chair, Tax Section Fringe Benefit Committee Chair, and in various other ABA leadership capacities. Ms. Stamer also is a former Southwest Benefits Association Board Member and Continuing Education Chair, SHRM National Consultant Board Chair and Region IV Chair, Dallas Bar Association Employee Benefits Committee Chair, former Texas Association of Business State, Regional and Dallas Chapter Chair, a founding board member and Past President of the Alliance for Healthcare Excellence, as well as in the leadership of many other professional, civic and community organizations. She also is recognized for her contributions to strengthening health care policy and charitable and community service resolving health care challenges performed under PROJECT COPE Coalition For Patient Empowerment initiative and many other pro bono service involvements locally, nationally and internationally.
Ms. Stamer is the author of many highly regarded works published by leading professional and business publishers, the ABA, the American Health Lawyers Association, and others. Ms. Stamer also frequently speaks and serves on the faculty and steering committee for many ABA and other professional and industry conferences and conducts leadership and industry training for a wide range of organizations.
For more information about Ms. Stamer or her health industry and other experience and involvements, see http://www.cynthiastamer.com or contact Ms. Stamer via telephone at (214) 452-8297 or via e-mail here.
About Solutions Law Press™
Solutions Law Press™ provides health care, insurance, human resources and employee benefit, data and technology, regulatory and operational performance, and other business risk management, legal compliance, management effectiveness and other coaching, tools and other resources, training and education. These include extensive resources on leadership, governance, human resources, employee benefits, data security and privacy, insurance, health care and other key compliance, risk management, internal controls and operational concerns. If you find this of interest, you also be interested reviewing some of our other Solutions Law Press™ resources or training.
If you or someone else you know would like to receive future updates about developments on these and other concerns, please be sure that we have your current contact information including your preferred e-mail by creating your profile here.
NOTICE: These statements and materials are for general information and purposes only. They do not establish an attorney-client relationship, are not legal advice or an offer or commitment to provide legal advice, and do not serve as a substitute for legal advice. Readers are urged to engage competent legal counsel for consultation and representation considering the specific facts and circumstances presented in their unique circumstances at the particular time. No comment or statement in this publication is to be construed as legal advice or an admission. Solutions Law Press and its authors reserve the right to qualify or retract any of these statements at any time. Likewise, the content is not tailored to any particular situation and does not necessarily address all relevant issues. Because the law constantly and often rapidly evolves, subsequent developments that could impact the currency and completeness of this discussion are likely. Solutions Law Press and its authors disclaim and have no responsibility to provide any update or otherwise notify anyone of any fact or law-specific nuance, change, limitation, or other condition that might affect the suitability of reliance upon these materials or information otherwise conveyed in connection with this program. Readers may not rely upon, are solely responsible for, and assume the risk and all liabilities resulting from their use of this publication.
Circular 230 Compliance. The following disclaimer is included to ensure that we comply with U.S. Treasury Department Regulations. Any statements contained herein are not intended or written by the writer to be used, and nothing contained herein can be used by you or any other person, for the purpose of (1) avoiding penalties that may be imposed under federal tax law, or (2) promoting, marketing or recommending to another party any tax-related transaction or matter addressed herein.
Employers should take note of recent changes made by the Citizenship and Immigration Services to the Form I-9, Employment Eligibility Verification and the Department of Homeland Security (“DHS”) Privacy Notice. While the updates don’t require employers to adopt the new I-9 Form until other current forms expire or are revoked, employers should know the changes to ease the administration of their I-9 requirements.
Form I-9
The revised Form I-9 with edition date 01/20/25 and expiration date 05/31/2027 includes minor changes to Form I-9 to align with statutory language.
Key updates include:
Renaming the fourth checkbox in Section 1 to “An alien authorized to work”
Revising the descriptions of two List B documents in the Lists of Acceptable Documents
Adding appropriate statutory language and a revised DHS Privacy Notice to the instructions.
While the revised Form I-9 with an edition date 01/20/25 is now available for download, multiple previous editions remain valid until their respective expiration dates:
Form I-9 (08/01/23 edition) that is valid until 05/31/2027
Form I-9 (08/01/23 edition) that is valid until 07/31/2026 (Employers using this form must update their electronic systems with the 05/31/2027 expiration date by July 31, 2026.)
E-Verify
Also, starting April 3, 2025, E-Verify and E-Verify+ will have updated the Citizenship Status selection during case creation to reflect this statutory language. The selection “A noncitizen authorized to work” will be updated to “An alien authorized to work.”
Employers should note:
If an employee attests on Form I-9 as “A noncitizen authorized to work,” the employer must select “An alien authorized to work” in E-Verify.
E-Verify cases will display “An alien authorized to work,” while employees and employers may continue to see “A noncitizen authorized to work” on Form I-9, depending on the form edition being used.
E-Verify+ participants will see the updated 01/20/25 edition date and 05/31/2027 expiration date reflected in Form I-9NG.
Additionally, E-Verify users creating cases through Web Services applications will see the employee status attestation automatically updated to “An alien authorized to work”—even if the WS application submits “A noncitizen authorized to work” if the employee selected citizenship status number four on Form I-9.
This change does not affect the current Interface Control Agreement (ICA) version 31.1, which already provides the necessary guidance for Web Services developers. WS developers should update their platforms to transmit “An alien authorized to work” instead of “A noncitizen authorized to work” as soon as possible.
The author of this update, Cynthia Marcotte Stamer is an attorney board certified in Labor and Employment Law by the Texas Board of Legal Specialization, with decades of experience advising employers and others about I-9 and other workforce, employee benefits, compensation, performance management, reengineering and other compliance, risk management and operational matters. If you have questions or need advice or help evaluating or addressing these or other compliance, risk management, or other concerns, contact her.
For More Information
We hope this update is helpful. For more information about these or other health or other employee benefits, human resources, or health care developments, please contact the author, Cynthia Marcotte Stamer, via e-mail or telephone at (214) 452-8297.
Solutions Law Press, Inc. invites you to receive future updates by registering on our Solutions Law Press, Inc. Website and participating and contributing to the discussions in our Solutions Law Press, Inc. LinkedIn SLP Health Care Risk Management & Operations Group, HR & Benefits Update Compliance Group, and/or Coalition for Responsible Health Care Policy.
About the Author
A Fellow in the American College of Employee Benefit Counsel, the American Bar Foundation and the Texas Bar Foundation; Cynthia Marcotte Stamer is an attorney board certified in labor and employment law by the Texas Board of Legal Specialization, management consultant, author, public policy advocate and lecturer sought out by clients and industry and government leaders for her more than 35 years of health, insurance, employment and employee benefits and other industry management work, thought leadership, public policy and regulatory affairs advocacy, coaching, teaching, and publications on health and other employee benefits, health care, insurance, workforce and other risk management and compliance.
Along with her decades of legal and strategic consulting experience, Ms. Stamer also contributes her leadership and experience to many professional, civic and community organizations. Along with currently serving as Co-Chair of the ABA Real Property Trusts and Estates (“RPTE”) Section Welfare Plan Committee, Co-Chair of the ABA International Section International Employment Law Committee and its Annual Meeting Program Planning Committee, Chair Emeritus and Vice Chair of the ABA Tort Trial and Insurance (“TIPS”) Section Medicine and Law Committee, and Chair of the ABA Intellectual Property Section Law Practice Management Committee, her previous ABA leadership roles include more than a decade of service as a Scribe for the Joint Committee on Employee Benefits (“JCEB”) annual agency meetings with the Department of Health and Human Services and JCEB Council Representative, International Section Life Sciences Committee Chair, RPTE Section Employee Benefits Group Chair and a Substantive Groups Committee Member, Health Law Section Managed Care & Insurance Interest Group Chair, as TIPS Section Medicine and Law Committee Chair and Employee Benefits Committee and Workers Compensation Committee Vice Chair, Tax Section Fringe Benefit Committee Chair, and in various other ABA leadership capacities. Ms. Stamer also is a former Southwest Benefits Association Board Member and Continuing Education Chair, SHRM National Consultant Board Chair and Region IV Chair, Dallas Bar Association Employee Benefits Committee Chair, former Texas Association of Business State, Regional and Dallas Chapter Chair, a founding board member and Past President of the Alliance for Healthcare Excellence, as well as in the leadership of many other professional, civic and community organizations. She also is recognized for her contributions to strengthening health care policy and charitable and community service resolving health care challenges performed under PROJECT COPE Coalition For Patient Empowerment initiative and many other pro bono service involvements locally, nationally and internationally.
Ms. Stamer is the author of many highly regarded works published by leading professional and business publishers, the ABA, the American Health Lawyers Association, and others. Ms. Stamer also frequently speaks and serves on the faculty and steering committee for many ABA and other professional and industry conferences and conducts leadership and industry training for a wide range of organizations.
For more information about Ms. Stamer or her health industry and other experience and involvements, see http://www.cynthiastamer.com or contact Ms. Stamer via telephone at (214) 452-8297 or via e-mail here.
About Solutions Law Press™
Solutions Law Press™ provides health care, insurance, human resources and employee benefit, data and technology, regulatory and operational performance, and other business risk management, legal compliance, management effectiveness and other coaching, tools and other resources, training and education. These include extensive resources on leadership, governance, human resources, employee benefits, data security and privacy, insurance, health care and other key compliance, risk management, internal controls and operational concerns. If you find this of interest, you also be interested reviewing some of our other Solutions Law Press™ resources or training.
If you or someone else you know would like to receive future updates about developments on these and other concerns, please be sure that we have your current contact information including your preferred e-mail by creating your profile here.
NOTICE: These statements and materials are for general information and purposes only. They do not establish an attorney-client relationship, are not legal advice or an offer or commitment to provide legal advice, and do not serve as a substitute for legal advice. Readers are urged to engage competent legal counsel for consultation and representation considering the specific facts and circumstances presented in their unique circumstances at the particular time. No comment or statement in this publication is to be construed as legal advice or an admission. Solutions Law Press and its authors reserve the right to qualify or retract any of these statements at any time. Likewise, the content is not tailored to any particular situation and does not necessarily address all relevant issues. Because the law constantly and often rapidly evolves, subsequent developments that could impact the currency and completeness of this discussion are likely. Solutions Law Press and its authors disclaim and have no responsibility to provide any update or otherwise notify anyone of any fact or law-specific nuance, change, limitation, or other condition that might affect the suitability of reliance upon these materials or information otherwise conveyed in connection with this program. Readers may not rely upon, are solely responsible for, and assume the risk and all liabilities resulting from their use of this publication.
Circular 230 Compliance. The following disclaimer is included to ensure that we comply with U.S. Treasury Department Regulations. Any statements contained herein are not intended or written by the writer to be used, and nothing contained herein can be used by you or any other person, for the purpose of (1) avoiding penalties that may be imposed under federal tax law, or (2) promoting, marketing or recommending to another party any tax-related transaction or matter addressed herein.